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ABSTRACT 
ANTI-DIABETIC POTENTIALS OF PHENOLIC ENRICHED CHILEAN POTATO 
AND SELECT HERBS OF APIACEAE AND LAMIACEAE FAMILIES 
SEPTEMBER 2010 
FAHAD SALEEM, B.S. UNIVERSITY OF MASSACHUSETTS AMHERST 
M.S., UNIVERSITY OF MASSACHUSETTS AMHERST 
Directed by: Dr. Kalidas Shetty 
 The incidence of diabetes mellitus and cardiovascular diseases is increasing at a 
worrisome rate globally. Diabetes mellitus is known to occur due to high blood glucose 
levels, caused by defects in insulin levels. Adult on-set type II diabetes, which is closely 
associated with obesity, is reported to be 90-95% of all diabetic cases and linked to diet 
and lifestyle factors. A large population of the developed and developing countries is now 
being effected by this epidemic. Natural sources of phenolic antioxidants and inhibitors 
of digestive enzymes from food sources have potential for low cost dietary management 
of type II diabetes. Therefore, the main focus of this study was to evaluate, develop and 
design effective dietary strategies based on a combination of Chilean potatoes and herb 
synergies for the management of hyperglycemia and hypertension linked to type II 
diabetes.  
 Antioxidant, antihypertensive and anti-hyperglycemic potentials of Chilean potato 
(Solanum tuberosum ssp. tuberosum L.), herbs from the Apiaceae (Dill, Ajowan, Fennel, 
Caraway, Coriander and Anise) and Lamiaceae (Sage and Marjoram) families were 
evaluated, with a goal to target a new dietary management strategy for early stages of 
 v
type II diabetes through lowering of hyperglycemia and related complications of 
hypertension  
 The results indicated a high correlation between total phenolic content and total 
antioxidant activity in several Chilean potato varieties evaluated, which indicates that 
certain phenolic compounds may be responsible for high antioxidant activity. Also, 
certain varieties of Chilean potato had antihypertensive potentials, with ACE inhibition 
upto 88%.  
 The α-glucosidase inhibition relevant for hyperglycemia management for 
Apiaceae family ranged upto 50% (Dill) for aqueous extracts. A high correlation (r = 
0.86) was observed between α-glucosidase inhibition and total phenolic content for 
aqueous extracts of all species investigated in the Apiaceae family. A high rosmarinic 
acid activity was observed in aqueous extracts of Lamiaceae family, which ranged upto 
39.7 mg/g of sample dry weight (DW). This suggests that high phenolic content and 
associated antioxidant activity found in sage and marjoram is dominated by rosmarinic 
acid.  
 High enzyme inhibitory activities, reflecting in vitro anti-hyperglycemic and anti-
hypertensive potentials indicates that consumption of these food sources in our diet 
would prove to be beneficial towards our health. Further in vivo studies for type II 
diabetes-linked functionalities of these natural sources of antioxidants and inhibitors 
would confirm the human health benefits achieved through dietary intake. 
Keywords: Angiotensin-I converting enzyme (ACE), Antioxidant Activity, α-
glucosidase, Chilean potato (Solanum tuberosum ssp. tuberosum L.), Apiaceae, 
Lamiaceae, Phenolic Content, Rosmarinic acid 
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 CHAPTER 1 
 
INTRODUCTION 
 
 Diabetes mellitus is now becoming a common metabolic disorder, resulting from 
the inability of our body’s response to high blood glucose levels. Type II diabetes 
mellitus is reported to be 90-95% of all diabetic cases (Schulze and Hu, 2005). The 
epidemic nature of type II diabetes is closely associated with obesity, and according 
to World Health Organization (WHO), more than 220 million people were suffering 
from it in 2009 (WHO. www.who.org). The number of people projected to suffer 
from type II diabetes is predicted to rise over 350 million by 2030 (Diet, nutrition and 
the prevention of chronic diseases, www.who.org).  
 Remarkable progress has been achieved in development of synthetic drugs, but 
investigations are being carried out to discover natural and cost-effective food sources 
for managing hyperglycemia and hypertension associated with early stages of type II 
diabetes, through diets rich in legumes, fruits, vegetables, herbs and spices. These 
plant foods consist of basic nutrients such as vitamins, minerals, dietary fibers and 
more important bioactive compounds such as polyphenols and carotenoids 
(Montonen et al., 2004; Robert et al., 2006) that can have specific structure-function 
benefits (Shetty et al., 2008; Pinto and Shetty, 2010). Consumption of these bioactive 
enriched plant foods has the potential to prevent and lower the occurrence of early 
stages of these chronic diseases such as type II diabetes, cardiovascular diseases and 
their late stage complications. Many plant foods and specific varieties of specific 
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 species contain hypoglycemic compounds, acting as antimetabolites to help block 
specific disease pathway, including the oxidation pathway of fatty acids (Ahmad et 
al., 2009). Plant sources utilized as medicinal herbs and seeds are known to have low 
toxicity levels and several therapeutic properties, due to which more recognition has 
been given to them as being safer than synthetic drugs. Natural plant and food sources 
provide α-amylase and α-glucosidase inhibitors, which plays a part in offering 
techniques to control postprandial hyperglycemia (Kwon et al., 2006; Shetty et al., 
2008; Pinto and Shetty, 2010) with minimum side effects. 
 Herbs and seeds of many plant sources are being evaluated to measure their levels 
of phenolic phyotchemicals, containing high antioxidant activity (Kwon et al., 2006). 
Phenolic phytochemicals are used by plants to protect them from abiotic and biotic 
stresses, but are equally also beneficial to preventing and combating human chronic 
diseases linked to oxidative stress (Shetty and Wahlqvist, 2004). The presence of 
certain phenolic compounds in plant foods are associated and highly correlated with 
high antioxidant activities along with high amounts of α-amylase and α-glucosidase 
inhibitors, which plays a role in the treatment of managing hyperglycemia and related 
complications of hypertension (Kwon et al.,2006; Shetty et al., 2008; Pinto and 
Shetty, 2010). 
 Therefore the aim of this thesis was to evaluate novel Chilean potato (Solanum 
tuberosum ssp. tuberosum L.) widely used as potato-based foods in the tropical and 
sub-tropical regions, as well as select species of the Apiaceae and Lamiaceae families 
used as condiments for their anti-diabetic and anti-hypertensive potentials. A 
synergistic combination of the right potato varieties with the right combination of 
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 condiments can be the basis of an effective dietary strategy for managing early stages 
of type II diabetes, associated hyperglycemia and its oxidation-linked micro vascular 
and macro vascular complications such as hypertension. 
 Potato originated from the Andean mountains (Andean potato – Solanum 
tuberosum ssp. andigenum L.) and also Chiloe Islands (Chilean potato – Solanum 
tuberosum ssp. tuberosum L.) of South America. Potato has been used as a food 
source since ancient times, but is commonly perceived as an unhealthy food item due 
to its high starch content and when fried with vegetable oils. It is amongst one of the 
most highly produced crops and the third largest food crop consumed, following rice 
and wheat (Camire et al., 2009). Phytochemicals in potato are often found in its peel, 
and its content is higher in cultivars with brighter peel colors (Zhang et al., 2009). 
Phytochemicals are relevant to human health in the form of antioxidants and associate 
bioactive functions for specific disease conditions, and the high daily consumption of 
potato could contribute a high phenolic content to our diet (Xu et al., 2009). Potato is 
known to have a low fat content, therefore its consumption in substitution for other 
high carbohydrate content foods such as rice and pasta may potentially benefit our 
overall health. Chilean potato (Solanum tuberosum ssp. tuberosum L.) used as genetic 
stock in developing tropical and sub-tropical varieties was chosen for the evaluation 
of its health benefits, in relation to total phenolics, antioxidant activity and in vitro 
enzyme inhibition assays (α-amylase, α-glucosidase and ACE), for potential 
prevention and management of early stages of type II diabetes. 
 Plants and especially medicinal and food herbs have been used as traditional 
medicine to treat common illnesses, since ancient times. Plants from the Apiaceae 
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 family are used as food, flavoring of foods and for their medicinal purposes, such as 
stomachaches, abdominal pain and acidity (Shekhawat and Batra, 2006). Previous 
studies have suggested that species belonging to the Apiaceae family have 
hypoglycemic effects on humans and animals (Dhandapani et al., 2002). To develop 
treatments for prevention of chronic illnesses, this study investigated the medicinal 
uses and phytotherapies of seeds from select species of family Apiaceae. The 
discovery of innovative ideas for the development of plant-based medicine and food-
based therapies would allow the availability of medicine at a lower cost compared to 
synthetic drugs. We evaluated the seed extracts of Foeniculum vulgare (Fennel), 
Anethum graveolens (Dill), Coriandrum sativum (Coriander), Trachyspermum 
copticum (Ajowan), Carum carvi (Caraway) and Pimpinella anisum (Anise) for their 
anti-diabetic potential. Evaluation of 6 select species of the family Apiaceae was done 
using in vitro assays, which provides the biochemical rationale to potentially target 
them for prevention of type II diabetes based on future animal and clinical studies. 
 Further it has been estimated that, presently, 80% of the world’s population relies 
on the use of traditional medicine for healthcare purposes (Muthu et al., 2006). 
Therefore, the awareness of specific herbs for medicinal use is becoming common for 
treating chronic illnesses. Herbs in the family Lamiaceae are known to be a rich 
source of phenolic antioxidants (Shetty, 1997; Kwon et al., 2006), which often 
indicates a high correlation with α-glucosidase inhibitors and therefore have the 
potential for prevention of hyperglycemia. Therefore another focus of this research 
study was to evaluate two select species of Lamiaceae family, such as Origanum 
majorana (Marjoram) and Salvia libanotica (Sage), for their hypoglycemic potential. 
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 Many plants from Lamiaceae family originated from Near East Asia, where they have 
been used for food preservation and treatment of common illnesses as traditional 
medicine and now widely used around the world (Shetty et al., 1995; Kwon et al., 
2006). Lamiaceae family herbs contain phenolic phytochemicals, which are linked to 
potentially managing chronic oxidation linked diseases (Shetty, 1997), and contains 
potential capacity to lower mortality rates of cancer (Velioglu et al., 1998). Therefore 
evaluating in vitro functionality assays would provide a biochemical rationale for the 
use of sage and marjoram in prevention of hyperglycemia and hypertension linked to 
type II diabetes. 
 In this thesis study, total soluble phenolics and DPPH inhibition assay to 
determine the total antioxidant activity and phenolic profile were evaluated to explore 
the potential of Chilean potato (Solanum tuberosum ssp. tuberosum L.), select 
Apiaceae family species and 2 Lamiaceae family species from the Near East region 
for potential use in the dietary management of early stages of hyperglycemia and 
hypertension. Specifically in vitro functionality assays such as α-amylase, α-
glucosidase and angiotensin-I converting enzyme (ACE) inhibitory activities were 
performed to evaluate the potential of studied samples towards hyperglycemia and 
hypertension management. 
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 CHAPTER 2 
 
LITERATURE REVIEW 
 
2.1 Hyperglycemia and Hypertension Linked to Type II Diabetes 
 
  The occurrence of type II diabetes is becoming a global epidemic which is 
essentially due to dramatic changes in diet and lifestyle. Diabetes is known to occur 
due to elevated blood glucose levels and the inability of a body’s response to high 
blood glucose, which is caused by defects in insulin secretion, insulin action (Schulze 
and Hu, 2005) and several other pathological changes. Diabetes mellitus is known to 
be effecting people of both developed and developing countries, harming a large 
percentage of the world’s population. Type II diabetes mellitus is reported to make up 
90% - 95% of all diabetic cases. It develops when the cellular sensitivity to insulin 
signaling is reduced (Schulze and Hu, 2005). Type I diabetes, which is caused due to 
complete deficiency of insulin secretion, is due to the destruction of pancreatic beta 
cells. It is believed that the reason behind increase in occurrence of type II diabetes is 
due to environmental risk factors, and for type I diabetes there are only a few known 
environmental risk factors that could potentially cause the disease (Schulze and Hu, 
2005). Previous studies have suggested that the adoption of Western diet (Van Dam et 
al., 2002), along with other risk factors such as obesity and the lack of physical 
activity are associated with increased incidence of type II diabetes. 
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  The number of people suffering from type II diabetes is rising constantly 
worldwide. Due to the increase from 35 million people with type II diabetes in 1985 
(Schulze and Hu, 2005) to more than 220 million people in 2009 (World Health 
Organization, www.who.org), we can assume that the epidemic nature of type II 
diabetes is due to environmental risk factors rather than genetic changes. Genetic 
background is unlikely to have changed the nature of type II diabetes due to the short 
time period. The incidence of type II diabetes is closely related to the worldwide 
epidemic of obesity, and the amount of people projected to have type II diabetes is 
predicted to increase over 350 million by 2030 (Diet, nutrition and the prevention of 
chronic diseases, www.who.org). 
 Cardiovascular diseases (CVD) are associated with type II diabetes as one of its 
main consequence, and majority of people effected with type II diabetes die of 
cardiovascular complications (Schulze and Hu, 2005). The risk of cardiovascular 
diseases in patients with type II diabetes is 2-6 times higher than people without type 
II diabetes (Gaede et al., 2003). Type II diabetes associated cardiovascular diseases 
and high incidence of micro vascular and macro vascular complications is also the 
leading cause of blindness, kidney failure and amputations (Gaede et al., 2003; 
Schulze and Hu, 2005). The direct medical cost of diabetes and diseases linked with 
diabetes is enormous, e.g., it was estimated to be over $132 billion in 2002 (Report 
from the American Diabetes Association, 2002). The rise in economic spending for 
type II diabetes is going to rise enormously, since the World Health Organization 
predicted that there is going to be over 350 million people affected with type II 
diabetes by 2030.  
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  There is no known cure for diabetes. Therefore bringing out awareness for 
changing the diet and lifestyle through which the occurrence of such illnesses could 
be reduced is the best strategy. There has been a remarkable progress and 
development in the therapy of type II diabetes mellitus through synthetic drugs. 
However, the investigation for anti-diabetic substances from natural sources for 
management of hyperglycemia and hypertension linked to type II diabetes is being 
pursued due to their lower toxicity and side effects (Ahmad et al., 2009; Pinto and 
Shetty, 2010).  
 Plant-based foods used for medicinal therapies have been used since ancient times 
to treat common illnesses. Recent studies have found activities of various plant foods 
containing anti-metabolites that help prevent the oxidation pathway of fatty acids 
(Ahmad et al., 2009), which has consequences for managing hypoglycemia. Natural 
α-amylase and α-glucosidase inhibitors from food-grade plants provide dietary 
strategies to control postprandial hyperglycemia, and the natural form of these 
inhibitors could be used in therapies with minimum side effects (Kwon et al., 2006; 
Shetty et al., 2008; Pinto and Shetty, 2010). Therefore, food-based biochemical 
studies on bringing awareness towards managing hyperglycemia and hypertension 
linked to type II diabetes through dietary management is gaining enormous 
importance. The inclusion of diets rich in fruits and vegetables compared to diets 
including red meat and sweets, independent of physical activity and family history of 
diabetes, indicates a lower risk for type II diabetes (Van Dam et al., 2002). Therefore, 
the diets rich in fruits and vegetables would also indicate a lower risk for 
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 cardiovascular complications, due to the high phenolic antioxidants and natural 
enzyme inhibitors. 
 
2.2 Chilean Potato (Solanum tuberosum ssp. tuberosum L.) 
 
  Potato belongs to the Solanaceae family, and originated from the Andean 
Mountains (Andean potato – Solanum tuberosum ssp. andigenum L.) and Chiloe 
Islands (Chilean potato – Solanum tuberosum ssp. tuberosum L.) of South America, 
where it has been used as a food source for thousands of years (Raker and Spooner, 
2002; Ames and Spooner, 2008). Potatoes (Solanum tuberosum ssp. tuberosum L.) 
grown in the Chilean region, as well as from the region of Venezuela and Argentina 
(Solanum tuberosum ssp. andigenum L.) are known as high yielding crops (Ames and 
Spooner, 2008). It has been known that Chilean potato is evolved from crossing of 
subspecies andigenum and an unidentified wild species (Grun, 1990; Raker and 
Spooner, 2002). There have been no studies carried out to explore the potential 
benefits of Chilean potato, in preventing and managing hyperglycemia and 
hypertension linked to type II diabetes. 
 Potato (Solanum tuberosum L.) is a highly produced food crop in the world, and 
the third largest food crop consumed, following rice and wheat (Camire et al., 2009). 
Potato is commonly believed to be unhealthy due to its high starch and high 
consumption when fried with oil, and many people are not aware of its health 
benefits. Often, it is believed that potato consists of high caloric and fat content 
compared to rice; which is incorrect since potato has a low fat and energy density, 
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 similar to legumes (Priestly, 2006; Camire et al., 2009). Consumption of potato in the 
right amount, right high bioactive variety and with low processing could potentially 
lead to the prevention of oxidation-linked chronic diseases such a type II diabetes and 
cardiovascular diseases as opposed to its usual form of French fries and potato chips. 
 Fruits and vegetables consist of nutrients such as vitamins, minerals and dietary 
fibers, as well as other bioactive compounds such as polyphenols and carotenoids 
(Montonen et al., 2004; Robert et al., 2006), which are beneficial towards human 
health (Shetty et al., 2008). Consumers are becoming more aware of the nutritional 
benefits such as high antioxidant activities from fruits and vegetables than ever 
before. Phytochemicals and specifically secondary metabolites like phenolics are 
produced by plants to protect themselves from abiotic and biotic stresses, but they 
could also potentially prove to be beneficial to manage human chronic diseases 
induced under oxidative stress for high calories and life style changes (Shetty and 
Wahlqvist, 2004). 
 The peel of potato is a good source of phytochemicals such as anthocyanins, and 
its content is higher in potatoes with brighter peel colors (Zhang et al., 2009). 
Anthocyanins are also known to have other biological functions such as high 
antioxidants, antimicrobial and anti-obesity capacities (Zhang et al., 2009), and the 
presence of anthocyanins in potato peel is 3-4 times higher than in the tuber. 
Phytochemicals are associated to human health in the form of antioxidants, and are 
associated with disease prevention abilities. Potato is usually not considered as a food 
item with high antioxidant activity, but due to its high daily consumption, it is known 
to contribute high total phenolic content to our diet (Xu et al., 2009). The high 
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 amount of antioxidants consumed through inclusion of potato in out diet could be 
related to efficiently helping defend our bodies from cardiovascular diseases, by 
limiting oxidative stress (Chu et al., 2002; Robert et al., 2006). 
 A important vitamin obtained from fruits and vegetables beneficial for human 
health is vitamin C, and potato is rich in vitamin C with the content of 15 mg/100 g of 
steamed potato (Robert et al., 2006). The amount of vitamin C in a potato contributes 
to 25-30% of our daily recommended dietary allowance (Robert et al., 2006). Pinto et 
al (2008), suggested that the presence of α-glucosidase inhibitors from certain plant 
foods contributes to management of hyperglycemia linked to type II diabetes. Since 
90% of the diabetic patients are suffering from type II diabetes, it is important that 
dietary α-glucosidase inhibitors are present, to prevent the absorption of glucose in 
small intestine (Ranilla et al., 2010). Therefore, type II diabetes could potentially be 
controlled via inhibition of α-glucosidase enzyme, which participates in digestion of 
carbohydrates. Potato varieties that have high α-glucosidase inhibitors can further be 
used in vivo experiments as part of a therapeutic strategy, for management of 
hyperglycemia linked to type II diabetes. Another inhibitor related to α-glucosidase 
inhibitor is α-amylase inhibitor, which is also known to play an important role in the 
management of hyperglycemia linked to type II diabetes (Pinto et al., 2009). The 
inhibitory activities of these two enzymes are often linked to certain phenolic 
compounds present in plant foods. Therefore, the inhibition of these enzymes could 
vary by being high or low depending on the presence of phenolic phytochemicals that 
enhance their activities in species specific plant species and varieties (Kwon et al., 
2006; Pinto et al., 2009). It has been suggested that inhibition of both α-glucosidase 
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 and α-amylase necessarily does not have to be present to help manage 
hyperglycemia, as long as one of the inhibitor types show a high activity (Pinto et al., 
2009). However foods with high α-glucosidase inhibitor and low or medium α-
amylase inhibitor are considered ideal to avoid digestive complications from 
undigested starch (Kwon et al., 2006). 
  Cardiovascular diseases are one of the leading causes of death in the 
world, and type II diabetes increases the susceptibility to cardiovascular diseases due 
to micro vascular and macro vascular complications. Diets rich in fruits and 
vegetables are recommended for hypertension management, along with 
hyperglycemia linked to type II diabetes (Bazzano et al., 2003). The combination of 
micronutrients, antioxidants, phytochemicals and fibers present in fruits and 
vegetables also help reduce the overall risk of cardiovascular diseases (Liu et al., 
2000). An important target for managing vascular complications includes angiotensin 
converting enzyme inhibition, which is used for treating hypertension associated with 
congestive heart failures. Angiotensin I-converting enzyme (ACE) regulates vascular 
hypertension by two different reactions (Johnston, 1992; Pinto et al., 2009). One way 
is to convert angiotensin I into a vasoconstrictor, angiotensin II, and vasodilator 
bradykinin that helps lower blood pressure (Johnston, 1992).  
 The different phenolic compounds from potato could be correlated with high or 
low ACE inhibitory activity. This would indicate the potential of regular intake of 
phenolic compounds through our diet for beneficial effects on cardiovascular system. 
Chlorogenic acid forms 90% of the total phenolic compounds in potato tuber (Dao 
and Friedman, 1992), which ensures the quality and safety of potato plant. 
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 Chlorogenic acid has the ability to lower blood pressure in hypertensive patients, and 
its derivative has shown to lower blood pressure in hypertensive rats (Cheplick, 
2010). Potato is also a good source of ferulic acid, supplying 5-70 mg/ 100 g, and a 
source of dietary antioxidant to prevent vascular complications and type II diabetes 
(Zhao et al., 2008). Another compound often observed in potatoes include caffeic 
acid, which is a natural antioxidant abundant in plant foods, and has been proven to 
be beneficial in cardiovascular complications by indicating hypotensive effects in 
hypertensive rats (Li et al., 2005). Catechin activity in potato indicates the prevention 
of type II diabetes (Matsui et al., 2007), cardiovascular complications and cancer 
prevention abilities (Nagao et al., 2007). The inclusion of catechins through 
consumption of potato, especially in high amounts is known to reduce fat, cholesterol 
levels and blood pressure (Nagao et al., 2007).  
 Therefore, the inclusion of whole potato in our diet, not in its usual form of 
French fries and potato chips, has potential health benefits by managing 
hyperglycemia and hypertension linked to type II diabetes. 
 
2.3 Apiaceae (Carrot) Family  
 
  The use of plant food sources and especially food herbs in traditional 
medicine has increased the interest in exploring their beneficial effects on human 
health. An estimated 70% of population globally utilizes traditional medicine 
obtained from plants to treat and cure various ailments (Jiofack et al., 2009). Plants 
from the family Apiaceae (Carrot) are commonly used as food, flavoring of foods and 
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 for their medicinal purposes. In particular, the seeds from family Apiaceae are known 
to be used as a household remedy for complications such as hypertension (Gilani et 
al., 2005). In other regions of the world such as India, plants from family Apiaceae 
are used to treat common ailments such as stomachaches, abdominal pain and acidity 
(Shekhawat and Batra, 2006). In India, a mixture of various plants is often consumed 
orally with water, or applied externally by massaging the abdomen with it 
(Shekhawat and Batra, 2006). In other parts of the world such as Cameroon, the use 
of plants from Apiaceae family are targeted in therapies for vomiting, appendicitis, 
ingestion, constipation and to treat mosquito bites (Jiofact et al., 2009). 
 Another ancient form of traditional medicine is known as ‘Ayurveda’, which uses 
the active ingredients from plants in treating various illnesses (Dhandapani et al., 
2002). The use of plants is due to their less toxic, as well as more free from side 
effects compared to synthetic products. Several plants belonging to the Apiaceae 
family are considered to have hypoglycemic effects on humans and animals 
(Dhandapani et al., 2002). The hypoglycemic effects of plants could possibly be due 
to insulin affect, either by increasing pancreatic secretion of insulin from the cells of 
islets of Langerhan’s or its release from bound insulin (Prasanna, 2000; Dhandapani 
et al., 2002). 
 Various beneficial effects have been observed for seed extracts belonging to the 
Apiaceae family, and following are the select species evaluated. Essential seed oils 
form Foeniculum vulgare (Fennel) such as anethole and limonene are used for 
medicinal purposes, and the seeds are also used as tranquilizers and tonics (Oktay et 
al., 2003). Aqueous extracts of fennel seeds are observed for their hypotensive effects 
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 in a dose related manner (Oktay et al., 2003). Anethum graveolens (Dill) and 
Trachyspermum copticum (Ajowan) seed extracts have been used to treat diarrhea, 
ingestion and common colds (Husain et al., 2008), and Dill is also fed to cows and 
goats for improving milk production (Lans et al., 2007). Ajowan seed oils have been 
suggested to treat medical problems affecting joints or painful muscle conditions 
(Husain et al., 2008). Coriandrum sativum (Coriander) seeds are often used as food 
flavoring agent and to treat ulcers (Husain et al., 2008). Carum carvi (Caraway) plant 
is beneficial in treatment and management of type II diabetes and cardiovascular 
diseases, and evokes beneficial effects on elevation of lipids in the bloodstream 
(Lemhadri et al., 2006). Pimpinella anisum (Anise) belongs to the Middle Eastern 
region, where it is used as an aromatic spice and to help in digestion (Arslan et al., 
2004). 
 Phenolic antioxidants are attributed to the therapeutic use of medicinal plants in 
managing hyperglycemia, by playing a part in causing delay in development of type 
II diabetes. High content of polyphenols and vitamins due to high total phenolic and 
total antioxidant activity, gives an excellent rationale for using plant sources for 
medicinal purposes. It has been suggested that the high antioxidant activity potential 
is often due to certain phenolic compounds (Kesilova et al., 2006). The usefulness of 
antioxidants in our diet could be described by slowing down the oxidation of fats 
(Yen and Duh, 1994), as well as being identified as free radicals or active oxygen 
scavengers (Oktay et al., 2003). The inclusion of antioxidants in our diet by various 
food sources could lead to weight loss, controlling obesity which is linked to type II 
diabetes. Natural sources of antioxidants have the capability to protect against free 
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 radicals and chronic diseases (Oktay et al., 2003), whereas synthetic sources of 
antioxidants are restricted due to their carcinogenicity (Zheng and Wang, 2001). 
 The use of natural herbal medicine for the prevention of blood pressure and type 
II diabetes is practiced worldwide (Loizzo et al., 2008). The α-glucosidase inhibition 
for select species of family Apiaceae suggests that, it would delay the degradation of 
oligosaccharides, decreasing the absorption of glucose, which would inhibit the 
increase in postprandial hyperglycemia (Loizzo et al., 2008). The high α-glucosidase 
inhibitory activity is often associated with high total phenolic content and antioxidant 
activity, which suggests that certain phenolic compounds are responsible for this 
action. Compared to α-glucosidase inhibitory activity being associated with either 
total phenolic content or antioxidant activity, it has been suggested that high α-
amylase inhibition is not linked to either of these activities (Cheplick et al., 2010). 
Excess α-amylase inhibition could lead to stomach distention and discomfort, even 
though α-amylase inhibitory activity has positive effects on prevention of 
hyperglycemia, linked to type II diabetes (Cheplick et al., 2010). Since Apiaceae 
family consists of moderate α-amylase inhibition and good α-glucosidase inhibition, 
it is considered a good candidate for managing early stage hyperglycemia linked to 
type II diabetes. 
 Hypertension is a known risk factor for various vascular complications, associated 
with long term diabetes (Kwon et al., 2006). Type II diabetes plays a part in elevating 
plasma lipids, which serves as a risk factor for coronary heart diseases (Chatterjea and 
Shinde, 1994; Dhandapani et al., 2002). The risk of vascular complications could be 
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 decreased by lowering of plasma lipid levels by dietary strategies (Kanne and McGee, 
1976; Scott, 1999; Dhandapani et al., 2002).  
 ACE inhibitory activity was not indicated for the family Apiaceae, which could 
be due to the absence of certain phenolic compounds. Phenolic profile analysis by 
HPLC helps recognize the phenolic phytochemicals in certain foods. Caffeic acid is 
known to be present in fruits and vegetables, and have anti-inflammatory and 
antioxidant properties (Son and Lewis, 2002). The presence of this compound in 
select species of Apiaceae family suggests its disease prevention potential for type II 
diabetes and vascular problems. The anti-cancer and antioxidant activities of phenolic 
compound, catechin, has attracted attention due to its benefits on human health. It is 
known that the ingestion of catechins is supposed to decrease waist size while 
reducing body fat (Nagao et al., 2007), and helping to slow down the incidence of 
type II diabetes by managing hyperglycemia. Rutin content is high in Apiaceae 
family, and it is known to have special effects on dilating blood vessels and 
improving interpenetration of veins (Wand et al., 2003). Rutin is a compound found 
in many kinds of plants, and it is reported to consist of anti-inflammatory and 
antioxidant activities. Its antioxidant activity is accountable for preventing oxidative 
stress in pancreatic beta cells (Heineke et al., 1993), (preventing the uncontrolled 
proliferation of damaged pancreatic beta cells, not resulting in diabetes). The 
presence of rosmarinic acid suggests that it could be targeted against the production 
of oxidation-linked diseases (Shetty and Wahlqvist, 2004). The presence of all the 
above phenolic compounds indicates that Apiaceae family has the ability to provide 
protection against oxidation linked diseases. 
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  Food designs and medicinal formulations using seeds from Apiaceae family and 
incorporating them into the use for therapeutic purposes would prove to be beneficial, 
due to its hyperglycemic inhibitory activities, linked to type II diabetes. 
 
2.4 Lamiaceae (Mint) Family 
 
  Many plants related to Lamiaceae family have been originated from the 
Middle Eastern region in Asia. Origanum majorana (Marjoram) and Salvia libanotica 
(Sage) belongs to Lamiaceae (Mint) family, and also includes plants such as rosemary 
and lavenders. Salvia is genera of plants considered to be widely diverse in Turkey, 
and used as traditional medicine to treat common colds and stomach disorders 
(Cuvelier et al., 1996). Water extracts of Salvia libanotica (Sage) in Middle East are 
used to treat common colds, coughs and as anti-inflammatory agents in the oral cavity 
(Farhat et al., 2001). Also, Origanum majorana (Marjoram) is rich in essential oils, 
characterized for high amount of phenolic compounds. In Middle East, marjoram is 
used as folk medicine particularly in the form of tea, prescribed for fever, sinus 
congestion, as well as used to treat nervous disorders (Qari, 2008). Previous studies 
have indicated that essential oils from sage and marjoram have antibacterial, 
antimicrobial and suppressive activities against tumor formation (Hilan et al., 1997; 
Farhat et al., 2001). Marjoram is important as it consists of anti-hepatoma and anti-
genotoxicity activities; reducing the number of cell and chromosomal aberrations 
(Qari, 2008). The characteristics of sage and marjoram observed through various 
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 studies have determined their importance in preventive role for managing type II 
diabetes. 
 Herbs from Lamiaceae family are also commonly used for food preservation, 
culinary flavors and treatment of common illnesses as traditional medicine (Kwon et 
al., 2006). Lamiaceae herbs are rich sources of phenolic phytochemicals and 
antioxidants (Kwon et al., 2006); which are highly correlated with α-glucosidase 
inhibitors, playing a potential role in hyperglycemia management. Plants belonging to 
Lamiaceae family are great sources of natural antioxidants, often used as spices and 
aromatic herbs. Therefore phenolic phytochemicals from Lamiaceae family in general 
have potential for managing chronic oxidation linked complications, such as 
cardiovascular diseases and type II diabetes (Shetty, 1997; Kwon et al., 2006). The 
antioxidant activity associated with phytochemicals is also linked potentially to 
lowering mortality rates of cancer in humans (Veioglu et al., 1998).  
 When considering suitable extracts, possible reason for higher phenolic content 
determined for aqueous extracts is due to high temperature during sample preparation, 
compared to ethanolic extracts (Seaberg et al., 2003; Chun et al., 2005). High 
concentration of phenolic phytochemicals observed for oregano confirms its high 
antioxidant and antimicrobial activity (Chun et al., 2005). High antioxidant activity 
associated with total phenolic content, allows the consumption of sage and marjoram 
in our diet to delay, or prevent the oxidation of lipids by inhibiting the propagation 
and oxidizing chain reaction (Zheng and Wang, 2001; Chun et al., 2005). The dietary 
phenolic antioxidants found as natural food sources, are important for delaying the 
development of chronic diseases, such as cardiovascular complications and cancers 
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 (Shetty, 1997; Akyon, 2002; Chun et al., 2005). The antioxidant activity of phenolic 
compounds may not be mainly due to phenolic content, but may be due to the redox 
properties, physico-chemical structure and nature of the individual phenolics 
(Kahkonen et al, 1999; Zheng and Wang, 2001; Parejo et al., 2002; Chun et al., 
2005). The potential of plant-based additives from sage and marjoram to prevent 
oxidative stress proves that, the substitution of natural plant extracts for synthetic 
source of antioxidants also have the potential to influence human health (Hinneburg 
et al., 2006; Martinez-Tome et al., 2001). These herbs have the potential to be 
industrially efficient due to their high phenolic antioxidants, slowing down the 
oxidative degradation of lipids (Wojdylo et al., 2007), and improving the quality and 
nutritional value of food. Pancreatic beta cells are damaged due to oxidative stress 
before they are proliferated. If damaged pancreatic beta cells are prevented from 
proliferating through cell repair or apoptosis, the possibility of incidence of diabetes 
could be reduced. The high antioxidant activity potentially suppresses the oxidative 
stress caused to pancreatic beta cells, reducing the risk of diabetes (Song et al., 2005; 
Bhandari et al., 2008). Therefore, plants from Lamiaceae family with high phenolic 
antioxidants could prevent the occurrence of diabetes, applied through dietary 
management strategies in early stages. 
 The incidence of type II diabetes is growing at a worrisome rate, mainly due to 
diet and lifestyle adopted in the developed and developing countries. Therefore, 
therapeutic approaches including food based plants as medicinal sources are being 
developed for prevention of chronic illnesses. Decreasing the risk of postprandial 
hyperglycemia through a therapeutic approach can be achieved by slowing the 
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 absorption of glucose, by inhibiting α-glucosidase enzyme in the digestive organs 
(Bhandari et al., 2008). Lamiaceae herb samples containing certain phenolic 
compounds such as rosmarinic acid, caffeic acid and rutin may have hypoglycemic 
effects, due to high α-glucosidase inhibitory activities. The consumption of 
Lamiaceae herbs as condiments would result in enhancement of our health, due to 
their potential health benefits in terms of α-glucosidase inhibition relevant to 
hyperglycemia linked to type II diabetes. Inclusion of these herbs in our diet would 
potentially reduce blood glucose concentration and lengthen the duration of 
carbohydrate absorption (Ye et al., 2002). This would serve to be important because 
lowering of the blood glucose level to normal is the most important part of treating 
persistent hyperglycemia, which is the characteristic of diabetes (Ye et al., 2002).
 Hypertension is a risk factor for formation of cardiovascular complications, 
related to long term diabetes (Kwon et al., 2006) and was investigated to explore the 
Lamiaceae species in this study. Further the phenolic compound often found to be 
abundant in plant sources, especially in Lamiaceae family is rosmarinic acid 
(Peterson and Simmonds, 2003) and could indirectly benefit hypertension 
management. Rosmarinic acid contains high antioxidant activity, providing protection 
against oxidation linked illnesses in general (Peterson and Simmonds, 2003), which 
could be the reason for high antioxidant activity generally seen for sage and 
marjoram. The presence of rosmarinic acid in plants belonging to Lamiaceae family 
would prevent and manage hyperglycemia associated and linked to obesity. Further in 
vivo studies would be essential for understanding the benefits of consuming 
rosmarinic acid-enriched herbs on human health. Caffeic acid is a phenolic compound 
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 which plays an important part in fruits and vegetables as an antioxidant. Rutin is a 
phenolic flavonoid found in many fruits and vegetables, which is used to provide 
protection against development of vascular diseases (Schramm and German, 1998). 
The presence of rutin would give us some evidence that targeting sage could be used 
to benefit human health by managing hypertension, linked to type II diabetes. 
 Clinical information on the functions of sage and marjoram from Lamiaceae 
family could be further applied in vivo studies for development of innovative 
ingredient designs and formulations, for therapeutic strategies, to prevent chronic 
illnesses associated with type II diabetes and its complications. 
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 CHAPTER 3 
 
OBJECTIVES 
 
3.1 Chilean Potato (Solanum tuberosum ssp. tuberosum L.) 
  
(a) To study the phenolic-linked anti-diabetic potential of 54 sub-
tropical cultivars of Chilean potato. 
 
(b) Study the α-Glucosidase, α-Amylase and Angiotensin-I 
Converting Enzyme (ACE) inhibitory activities. 
 
(c) To screen antioxidant, anti-hypertensive and anti-diabetic 
potentials. 
 
(d) Determine functionalities of potato for better dietary management 
and future cultivar recommendation for potentially managing early 
stage type II diabetes through diet. 
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 3.2 Apiaceae (Carrot) Family 
 
(a) To study the medicinal uses and phytotherapies of six select 
species from Apiaceae family with a focus on their seeds. 
 
(b) To investigate the functionalities of select species and how their in 
vitro effects could provide the biochemical rationale to potentially 
target them towards prevention of type II diabetes. 
 
(c) Evaluate total soluble phenolics and DPPH inhibition assay to 
determine the total antioxidant activity and phenolic content of 
seeds. 
 
(d) Study in vitro assays such as α-glucosidase, α-amylase and ACE 
inhibitory activities to evaluate seeds potential treatment of 
hyperglycemia and hypertension management.  
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 3.3 Lamiaceae (Mint) Family 
 
(a) To screen two species (Origanum majorana and Salvia libanotica) 
belonging to the Lamiaceae family from Near East Asia. 
 
(b) Evaluate in vitro assay such as total soluble phenolic and inhibitory 
assays such as DPPH, α-glucosidase, α-amylase and ACE. 
 
(c) To provide the biochemical rationale for use of sage and marjoram 
in prevention of hyperglycemia and hypertension linked to type II 
diabetes. 
 
(d) To determine individual phenolic compounds found through HPLC 
analysis of phenolic phytochemicals, allowing us to correlate the 
phenolic compounds of the herbs to total antioxidant activity and 
total phenolics content.  
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 CHAPTER 4 
 
ANTI-HYPERTENSIVE AND ANTI-HYPERGLYCEMIC MANAGEMENT 
 
4.1 Evaluation of Cultivars of Chilean Potatoes (Solanum tuberosum ssp. 
tuberosum L.) for Diabetes and Hypertension Management Potential Using In Vitro 
Models 
 
4.1.1 Abstract 
 
  The rate of type II diabetes is increasing globally at a worrisome rate, 
especially due to high rates of obesity. Water extracts of 54 different Chilean potato 
(Solanum tuberosum ssp. tuberosum L.) varieties were evaluated for total phenolics and 
antioxidant activity by 2, 2-diphenyl-1-picrydrazyl (DPPH) radical scavenging assay. In 
vitro functionality assays such as inhibition of α-glucosidase and α-amylase relevant for 
anti-hyperglycemia potential and angiotensin I-converting enzyme (ACE) for anti-
hypertension potential were evaluated. The total phenolic content ranged from 0.92 mg/g 
(PA 43) to 13.1 mg/g (PA 4) of sample dry weight. A high correlation (r = 0.83) was 
observed for total phenolics and antioxidant activity by DPPH assay. Moderate activity of 
α-glucosidase inhibition was observed in several varieties with no α-amylase inhibitory 
activity. The anti-hypertensive potential of Chilean potato was high in select varieties, 
with the line PA 17 having 88% ACE inhibition. These in vitro assays indicate that sub-
tropical cultivars of Chilean potatoes have anti-hyperglycemia and anti-hypertensive 
potentials, which could be part of breeding lines to develop whole potato food products 
for effective diet designs. These diet designs based on animal and clinical studies can be 
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 targeted for managing early stages of type II diabetes when glucose management and 
exercise can help better manage overall state of this chronic disease. 
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 4.1.2 Practical Applications 
 
 In this study, we evaluated 54 sub-tropical Chilean potato (Solanum tuberosum 
ssp. tuberosum L.) varieties to determine their relevance in managing hyperglycemia and 
hypertension relevant for type II diabetes using in vitro models. This study established 
that some Chilean potato varieties have the potential to manage hypertension and 
hyperglycemia. The whole potato food products from such varieties could be part of food 
designs and could be part of effective breeding programs to develop potato varieties with 
health potential. This research gives us biochemical rationale for further in vivo animal 
and clinical studies based on the in vitro enzyme assay models. This study can potentially 
provide us with strategies to develop new food designs based Chilean potato breeding 
stocks which can be parts of diverse diet designs with more effective potential for 
reducing hypertension and hyperglycemia linked to type II diabetes. 
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 4.1.3 Introduction 
 
 Consumption of diets rich in fruits and vegetables are associated with lower 
occurrence of type II diabetes and cardiovascular diseases, which are supported by 
several biological and nutritional reasons. Fruits and vegetables consist of nutrients such 
as vitamins, minerals and dietary fibers, as well as other bioactive compounds such as 
polyphenols and carotenoids with potential health benefits (Montonen et al., 2004; Shetty 
and Wahlqvist, 2004; Robert et al., 2006; Shetty et al., 2010). 
 Several studies have indicated that the current global diabetes epidemic is due to 
dramatic changes in diet and lifestyle. Diabetes results from elevated blood glucose levels 
which are caused by defects in insulin production and secretion in response to glucose 
from dietary sources. Type II diabetes is reported to be 90%-95% of all diabetic cases, 
and it develops when the production of insulin is insufficient to overcome the underlying 
abnormality of increased glucose from the diet leading to increased resistance to its 
action (Schulze and Hu, 2005)). According to World Health Organization, in 2009 more 
than 220 million people were affected with type II diabetes, and the diabetes epidemic is 
closely related to the worldwide epidemic of obesity (World Health Organization, 
www.who.org). The 220 million people currently living with type II diabetes is predicted 
to increase to over 350 million by 2030 (Diet, nutrition and the prevention of chronic 
diseases, www.who.org). 
 Potato belongs to the Solanaceae family and originated from the Andean 
mountains (Andean potato - Solanum tuberosum ssp. andigenum L.) and Chiloe Islands 
(Chilean potato - Solanum tuberosum ssp. tuberosum L) of South America, where it has 
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 been used as a food source for thousands of years. It is commonly believed that potato is 
unhealthy due to its high starch content and oil content when fried, and many people are 
not aware of its health benefits from a range of other nutritional compounds such as 
vitamins and bioactive phenolics., Potato is known to be one of the highly produced 
starch crops in the world for quick source of calories, and third largest food crop 
consumed in the world following rice and wheat (Camire et al., 2009). Potatoes are a 
good source of starch when consumed in whole food form with energy density similar to 
legumes (Camire et al., 2009; Priestly, 2006) with additional potential from bioactive 
phenolic antioxidants. 
 Today, consumers are more aware of health benefits of antioxidants from fruits 
and vegetables than ever in addition to their nutritional benefits from minerals and 
vitamins. Phytochemicals and secondary metabolites like phenolics are produced by 
plants to protect it from abiotic and biotic stresses, but they are also beneficial to humans 
under disease induced oxidative stress (Shetty and Wahlqvist, 2004). Anthocyanins are 
phenolic phytochemicals that are typically found in the peel of potatoes, and its content is 
higher in cultivars that consist of brighter peel colors (Zhang et al., 2009). Antoxidant 
phytochemicals are known to have disease prevention abilities which are associated with 
overall human health. Generally, potato is not considered a high antioxidant containing 
food based on refined starch products, but due to its high daily consumption from whole 
food form and products it is known to contribute high total phenolic content to our diet 
(Xu et al., 2009). 
 Increased carbohydrates and its conversion to fat in addition to fat intake have 
been suggested to promote weight gain and obesity, contributing to type II diabetes. High 
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 fat intake in diet may also cause insulin resistance, independent of obesity (Diet, nutrition 
and the prevention of chronic diseases, www.who.org). Addition of potatoes in whole 
food with low deep frying to our diet compared to other high content carbohydrate foods 
such as rice and pasta may benefit our health due to its lower fat content. In addition 
factors such as enhanced physical activity with reduced smoking and consumption of 
alcohol are known to reduce the risk of type II diabetes by maintaining a healthy body 
weight and lifestyle. 
 Therapeutic and clinical strategies that manage type II diabetes is through the 
reduction of glucose by decreasing starch hydrolysis via blocking the pancreatic α-
amylase (Pinto et al., 2009). Also, α-glucosidase enzyme is used to prevent intestinal 
glucose absorption with dietary strategies being potentially safer (Kwon et al., 2006). The 
natural forms of α-glucosidase and α-amylase inhibitors that we ingest through our daily 
diet have potential to prevent hyperglycemia helping manage the incidence of type II 
diabetes. Angiotensin I-converting enzyme (ACE) regulates vascular hypertension via 
two different reactions (Johnston, 1992; Pinto et al., 2009). One way is to convert 
angiotensin I into a vasoconstrictor, angiotensin II, and vasodilator bradykinin that helps 
in lowering blood pressure (Johnston, 1992). Hypertension could be enhanced due to 
occurrence of type II diabetes; therefore, the inhibition of ACE could be helpful in 
decreasing hypertension linked to complications of type II diabetes. Therefore, the main 
objective of this study was to evaluate health benefits of Chilean potato (Solanum 
tuberosum ssp. tuberosum L.), in relation to total phenolics, antioxidant activity by DPPH 
and in vitro enzyme inhibition (α-amylase, α-glucosidase, and ACE) for potential 
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 reduction of hyperglycemia and hypertension for overall dietary management of type II 
diabetes. 
 The phenolic-linked anti-diabetic potential of 54 sub-tropical cultivars (varieties) 
of Chilean potato was evaluated. The screening of health-linked functional potential in 
these potato cultivars can help us to make cultivar recommendation and better varieties 
for potentially managing early stage type II diabetes through diet. 
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 4.1.4 Materials and Methods 
 
4.1.4.1 Materials 
 Dried samples of 54 different cultivars of sub-tropical Chilean potatoes 
(Solanum tuberosum ssp. tuberosum L.) were received from Puerto Montt, Chile. Porcine 
pancreatic α-amylase (EC 3.2.1.1), rat intestinal α-glucosidase (EC 3.2.1.20), hippuric 
acid, 2,2-diphenyl-1-picrylhydrazyl (DPPH), rabbit lung ACE (EC 3.4.15.1), cinnamic 
acid, rosmarinic acid, protocatechuic acid, p-coumaric acid, chlorogenic acid, caffeic 
acid, ferulic acid, and quercetin were purchased from Sigma Chemical Co. (St. Louis, 
MO). 
 
4.1.4.2 Sample Preparation 
 
Water Extracts:  
 The samples (2.5 g) were extracted in 100 mL of distilled water under reflux at 
95°C for 30 minutes. The samples were centrifuged for 10 minutes.  
 
4.1.4.3 Total Soluble Phenolic Assay 
 
The total phenolics in all samples were determined by using a method modified 
by Shetty et al. (1995). In brief, 0.5 mL of sample extract was added to a test tube and 
mixed with 0.5 mL of 95% ethanol and 5 mL of distilled water. To each sample, 0.5 mL 
of 50% (vol/vol) Folin-Ciocalteu reagent was added and mixed. The absorbance was read 
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 at 725 nm using a spectrophotometer (Genesys UV/Visible, Milton Roy, Inc., Rochester, 
NY). Different concentrations of gallic acid were used to develop a standard curve. 
Results were expressed as mg of gallic acid/g of sample dry weight (DW). 
 
4.1.4.4 Total Antioxidant Activity by DPPH Radical Inhibition Assay 
 
The antioxidant activity was determined by the DPPH radical scavenging method 
modified from Kwon et al. (2006). A 250 μL aliquot of the sample extract was mixed 
with 1,250 μL of DPPH (60 μM in ethanol). The mixture was centrifuged at 13,000 g for 
1 minute, and after this the absorbance was measured at 517 nm using the Genesys 
UV/Visible spectrophotometer. The readings were compared with the controls, 
containing 95% ethanol instead of sample extract. The percentage inhibition was 
calculated by: 
 
100)( = inhibition %
control
extractcontrol ×−
Absorbance
AbsorbanceAbsorbance  
 
4.1.4.5 α-Amylase Inhibition Assay 
 
The α-amylase inhibitory activity was determined by an assay modified from the 
Worthington Enzyme Manual (Worthington, 1993). A total of 500 µL of sample extract 
and 500 µL of 0.02 M sodium phosphate buffer (pH 6.9 with 0.006 M NaCl) containing 
α-amylase solution (0.5 mg/mL) were incubated at 25°C for 10 minutes. After 
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 preincubation, 500 µL of a 1% starch solution in 0.02 M sodium phosphate buffer (pH 
6.9 with 0.006 M NaCl) was added to each tube at timed intervals. The reaction was 
stopped with 1.0 mL of dinitrosalicylic (DNS) acid color reagent. The test tubes were 
incubated in a boiling water bath for 5 minutes and cooled to room temperature. The 
reaction mixture was then diluted after adding 5-15 mL of distilled water, and the 
absorbance was measured at 540 nm using the Genesys UV/Visible spectrophotometer. 
The readings were compared with the controls, containing buffer instead of sample 
extract. The percentage α-amylase inhibitory activity was calculated with the same 
equation as for percentage inhibition in the DPPH radical inhibition assay.  
 
4.1.4.6 α-Glucosidase Inhibition Assay 
 
The α-glucosidase inhibitory activity was determined by an assay modified from 
McCue et al. (2005). α-Glucosidase was assayed by using 50 μL of sample extracts and 
100 μL of 0.1 M phosphate buffer (pH 6.9) containing α-glucosidase solution (1 U/mL) 
and was incubated in 96-well plates at 25°C for 10 min. After preincubation, 50 μL of 5 
mM p-nitrophenyl-α-d-glucopyranoside solution in 0.1 M phosphate buffer (pH 6.9) was 
added to each well at timed intervals. The reaction mixtures were incubated at 25°C for 5 
min. Before and after incubation, absorbance readings were recorded at 405 nm by a 
microplate reader (Thermomax, Molecular Devices Co., Sunnyvale, CA) and compared 
to a control that had 50 μL of buffer solution in place of the extract. The α-glucosidase 
inhibitory activity was expressed as percentage inhibition and was calculated with the 
same equation as for percentage inhibition in the DPPH radical inhibition assay. Dose 
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 dependency was tested using 25 µL and 10 µL of the sample, the volume made up to 50 
µL using 0.1 M phosphate buffer (pH 6.9) and same protocol was followed. 
 
4.1.4.7 ACE Inhibition Assay 
 
ACE inhibition was assayed by a method modified by Kwon et al. (2006). The 
substrate hippuryl-histidyl-leucine (HHL) and the enzyme ACE-I from rabbit lung (EC 
3.4.15.1) were used. Fifty μL of sample extracts were incubated with 100 μL of 1 M 
NaCl-borate buffer (pH 8.3) containing 2 mU of ACE-I solution at 37°C for 10 min. 
After preincubation, 100 μL of a 5 mU substrate (HHL) solution was added to the 
reaction mixture. Test solutions were incubated at 37°C for 1 hour. The reaction was 
stopped with 150 μL of 0.5 N HCl. Five μL of the sample was injected in a high-
performance liquid chromatography (HPLC) apparatus (Agilent 1100 series equipped 
with autosampler and DAD 1100 diode array detector, Agilent Technologies, Palo Alto, 
CA). The solvents used for gradient were (1) 10 mM phosphoric acid (pH 2.5) and (2) 
100% methanol. The methanol concentration was increased to 60% for the first 8 min and 
to 100% for 5 min and then was decreased to 0% for the next 5 min (total run time, 18 
min). The analytical column used was an Agilent Nucleosil 100-5C18, 250 mm × 4.6 mm 
inside diameter, with packing material of 5 μm particle size at a flow rate of 1 ml/min at 
ambient temperature. During each run, the absorbance was recorded at 228 nm, and the 
chromatogram was integrated using the Agilent Chemstation (Agilent Technologies) 
enhanced integrator for detection of liberated hippuric acid (A). Hippuric acid standard 
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 was used to calibrate the standard curve and retention time. The percentage inhibition 
was calculated by: 
% inhibition =  (Acontrol − Aextract )
(Acontrol − Ablank )
×100
 
 
4.1.4.8 HPLC Analysis of Phenolic Phytochemicals 
 
Two milliliters of the extracts was filtered (pore size, 0.2 μm), and 5 μL was 
injected in the HPLC apparatus (Agilent 1100 series equipped with autosampler and 
DAD 1100 diode array detector). The solvents used for gradient elution were (A) 10 mM 
phosphoric acid (pH 2.5) and (B) 100% methanol. The methanol concentration was 
increased to 60% for the first 8 minutes and to 100% over the next 7 minutes, then 
decreased to 0% for the next 3 minutes, and maintained for the next 7 minutes (total run 
time, 25 minutes). The analytical column used was an Agilent Zorbax SB-C18, 250 mm 
× 4.6 mm i.d., with packing material of 5 μm particle size at a flow rate of 1 mL/minute 
at ambient temperature. During each run the absorbance was recorded at 306 nm and 333 
nm, and the chromatogram was integrated using the Agilent Chemstation enhanced 
integrator. Calibration was performed by injecting the standards of cinnamic acid, 
rosmarinic acid, protocatechuic acid, p-coumaric acid, chlorogenic acid, caffeic acid, 
ferulic acid, and quercetin. Peak identification was performed by comparison of retention 
times and diode array spectral characteristics with the standards. The results were 
expressed as μg/g of sample DW. 
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 4.1.4.9 Statistical Analysis 
 
All experiments were performed in either duplicates or triplicates. Analysis at 
every time point from each experiment was carried out in duplicate or triplicate. Means, 
standard errors and standard deviations were calculated from replicates within the 
experiments and analyzed using Microsoft Excel XP. 
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 4.1.5 Results and Discussion 
 
4.1.5.1 Total Soluble Phenolics and Antioxidant Activity 
  
 Potato has known to be domesticated in the Andes of Southern Peru about 10,000 
years ago (Ames and Spooner, 2008). The type of potato grown in Chile (Solanum 
tuberosum ssp. tuberosum L.) is known to be one of the highest yielding, along with 
potatoes from the region of Argentina and Venezuela (Ames and Spooner, 2008). Not 
many studies have been carried out to explore the health benefits of Chilean potato 
(Solanum tuberosum ssp. tuberosum L.), in the context of its relevance for managing of 
type II diabetes and hypertension through the diet. Although, it is known that the 
consumption of potato with higher nutritional and bioactive profiles has the potential to 
manage chronic diseases, its consumption in processed and fried forms such as French 
fries and potato chips has raised health concerns. Such high fat processed forms 
potentially increase risks for obesity-linked chronic diseases due to very high calorie 
intake from higher than normal servings. 
 The amounts of total phenolic content between the 54 different Chilean potato 
(Solanum tuberosum ssp. tuberosum L.) cultivars (varieties) were evaluated. The different 
colors of potato samples indicated that, bright color potato samples potentially have 
higher antioxidant and phenolics activity. Anthocyanins have been known to have 
biological functions such as high antioxidant, antimicrobial and anti-obesity potential 
(Zhang et al., 2009). It has been reported that, purple color of potato seems to be an 
indication of anthocyanin presence, which is 3-4 times higher in the potato peel compared 
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 to tuber (Zhang et al., 2009). The variations ranged with high total phenolic content for 
dark colors (purple, red and pink) and low phenolic content for light colors (white and 
yellow) potatoes. Therefore we can assume that different peel colors of potato affects the 
activity of antioxidants in a particular sample. The sample extraction method utilized was 
the same for all 54 samples of Chilean potato (Solanum tuberosum ssp. tuberosum L.), 
where 2.5 g of sample was extracted in 100 mL of water at 95°C for 30 minutes. Based 
on these studies, enhancement and development of potato in accordance to increasing 
their phenolic content would prove to be beneficial as a diet based management of 
oxidation-linked chronic diseases such as type II diabetes. 
 Therefore, in this study, we focused on aqueous extracts of 54 different samples 
of Chilean potato (Solanum tuberosum ssp. tuberosum L.), which were further evaluated 
for hyperglycemia-linked anti-diabetic potentials and also for complications such as 
hypertension using the appropriate in vitro assays as rapid screening tool. Figures 1, 2 
and 3 illustrate the results for total phenolic content and total antioxidant activity of 
aqueous extracts for all samples. The total phenolic content of Chilean potatoes ranged 
from 0.92 mg/g (PA 43) to 13.1 (PA 4) mg/g of sample dry weight (DW). The total 
phenolic content of all these samples showed a high correlation (r = 0.83) with 
antioxidant activity by DPPH assay. Observing the sample colors indicated that high 
phenolic and antioxidant activities were related with darker colors compared to low 
activities linked to white and yellow varieties. In this study, many potato samples 
consisted of high phenolic and antioxidant activity in aqueous extracts, which indicates 
its potential for a good source of phenolic antioxidants. 
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  The most important vitamin obtained from fruits and vegetables for human health 
and nutrition is vitamin C. Potato is rich in vitamin C with the content of 15 mg/100 g of 
steamed potato (Robert et al., 2006). The amount of vitamin C in a potato contributes to 
25-30% of our recommended dietary allowance (Robert et al., 2006). The high amount of 
overall antioxidants from both phenolics and vitamin C in potatoes can support our 
bodies against oxidative complications linked to type II diabetes and cardiovascular 
diseases, by limiting oxidative stress (Chu et al., 2002; Robert et al., 2006). Figures 1, 2 
and 3 show the results for overall antioxidant activity by DPPH assay for 54 different 
Chilean potato varieties. The in vitro antioxidant potential measured via DPPH inhibition 
assay for potato samples ranged from 5.8% (PA 29) to 77% (PA 21). We can assume 
that, Chilean potatoes with high antioxidant activity can be beneficial towards limiting 
the oxidative stress and helping to manage the micro vascular oxidative stress-linked 
complications of hyperglycemia and hypertension. High positive correlation was found 
between total phenolics and antioxidant activity through DPPH assay for aqueous 
extracts (r = 0.83). 
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Figure 1 Total Soluble Phenolics (mg GAE/ g DW ± Standard Error) and Total Antioxidant 
Activity (% DPPH Inhibition ± Standard Error) correlation of Chilean Potatoes (Solanum 
tuberosum ssp. tuberosum L.) for samples PA 1-18. 
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Figure 2 Total Soluble Phenolics (mg GAE/ g DW ± Standard Error) and Total Antioxidant 
Activity (% DPPH Inhibition ± Standard Error) correlation of Chilean Potatoes (Solanum 
tuberosum ssp. tuberosum L.) for samples PA 19-36. 
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Figure 3 Total Soluble Phenolics (mg GAE/ g DW ± Standard Error) and Total Antioxidant 
Activity (% DPPH Inhibition ± Standard Error) correlation of Chilean Potatoes (Solanum 
tuberosum ssp. tuberosum L.) for samples PA 38-54. 
 
 
 
4.1.5.2 α–Glucosidase Inhibition Assay 
 
 In this study, we investigated health benefits of Chilean potato (Solanum 
tuberosum ssp. tuberosum L.) for its hyperglycemic management potential linked to type 
II diabetes. According to World Health Organization, 90% of people suffering from 
diabetes mellitus around the world have type II diabetes (World Health Organization, 
www.who.org). Type II diabetes is characterized through a constant increase in blood 
glucose levels due to breakdown of starch foods by α- amylase and absorption of glucose 
in small intestine by α–glucosidase (Ranilla et al., 2010). α–Glucosidase inhibitory 
enzyme contributes in management of hyperglycemia, linked to type II diabetes (Pinto et 
al., 2008; Shetty et al., 2010). Therefore early stages of type II diabetes could be 
controlled via inhibition of α–glucosidase, which participates in the overall digestion and 
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 uptake of carbohydrates from the diet. Varieties that indicate high α–glucosidase 
inhibitory activities can be further used in vivo studies as part of therapeutic or clinical 
strategy, for managing hyperglycemia linked to type II diabetes. 
 Dose dependency (10 µL, 25µL, 50µL) of all samples evidently indicated dose 
dependent response. Figures 4, 5 and 6 illustrate results of α–glucosidase inhibition for all 
samples. The in vitro α–glucosidase inhibitory activity ranged from 0% (PA 17*, 35, 36, 
38, 39, 40, 41, 52, 53, 54) to 59% (PA 13), and a large scale of variation was seen 
between all 54 varieties of Chilean potato (Figure 4-6).  
 Extraction method for sample preparation was the same for α–glucosidase 
inhibition assay, which is described above. Samples with no dilution (50 µL), indicated 
the highest inhibition. Moderate correlation was observed between α–glucosidase 
inhibition and total phenolic content for aqueous extracts of all samples (r = 0.50). Also, 
a moderate correlation was seen between antioxidant activity through DPPH assay and α–
glucosidase inhibition (r = 0.54). We can therefore suggest that total phenolic content 
and free radical-linked antioxidant activity is associated with α–glucosidase inhibitory 
activity, since a moderately good correlation was observed. Also, these correlations may 
suggest that the highest inhibition of α–glucosidase could be due to darker colors of 
potato skins compared to lighter ones. Therefore, inhibitors in various skin samples of 
Chilean potato can be utilized in therapeutic strategies to manage hyperglycemia. These 
therapies and clinical strategies should be applied in early stages to manage 
hyperglycemia for the prevention of type II diabetes. 
 
                                                                       44
 0
10
20
30
40
50
60
70
80
90
100
PA
 1
PA
 2
PA
 3
PA
 4
PA
 5
PA
 6
PA
 7
PA
 8
PA
 9
PA
 10
PA
 11
PA
 12
PA
 13
PA
 14
PS
 15
PS
 16
PA
 17
PA
 17
*
PA
 18
Sample (Dilution)
%
 In
hi
bi
tio
n
1/5 Dilution
1/2 Dilution
No Dilution
 
Figure 4 Changes observed in dose dependent (10 µL, 25 µL and 50 µL) percent α-
glucosidase inhibitory activity of Chilean Potatoes (Solanum tuberosum ssp. tuberosum 
L.) for samples PA 1-18. 
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Figure 5 Changes observed in dose dependent (10 µL, 25 µL and 50 µL) percent α-
glucosidase inhibitory activity of Chilean Potatoes (Solanum tuberosum ssp. tuberosum 
L.) for samples PA 19-36. 
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Figure 6 Changes observed in dose dependent (10 µL, 25 µL and 50 µL) percent α-
glucosidase inhibitory activity of Chilean Potatoes (Solanum tuberosum ssp. tuberosum 
L.) for samples PA 38-54. 
 
 
 
4.1.5.3 α- Amylase Inhibition Assay 
 
 α-Amylase is another enzyme similar to α–glucosidase, which is known to have 
an important role in managing hyperglycemia linked to type II diabetes, though strong 
inhibition could lead to undigested starch-linked side-effects (Kwon et al., 2006; Pinto et 
al., 2009). In vitro α-amylase inhibition was evaluated for all 54 Chilean potato (Solanum 
tuberosum ssp. tuberosum L.) varieties, with the same protocol for aqueous sample 
preparation as rest of the inhibition assays described above. There was no α-amylase 
inhibition observed for any of the samples (PA 1-54). It has been suggested that α-
amylase inhibitory activity could possibly be related to some specific phenolic 
compounds (Pinto et al., 2009), which might not be present in samples observed in this 
study. Though α-amylase inhibitory activity is low the benefits of α–glucosidase 
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 inhibition is reasonable for select varieties to be considered as a component of a whole 
food design that can be part of our diet to help manage hyperglycemia linked to type II 
diabetes in its early stages (Pinto et al., 2009; Shetty et al., 2010). 
 
4.1.5.4 ACE Inhibition Assay 
 
 Cardiovascular diseases (CVD) are known to be one of the leading causes of 
deaths worldwide. Diets rich in fruits and vegetables are recommended for prevention of 
CVD, and its consumption lowers the risk of CVD including hypertension, which is a 
macro vascular complication of type II diabetes (Bazzano et al., 2003; Kwon et al., 
2006). Fruits and vegetables include combinations of micronutrients, antioxidants, 
phytochemicals and fibers which may be able to reduce the risk of cardiovascular 
diseases (Liu et al., 2000). ACE inhibition is an important target for hypertension 
management, and in this study we have evaluated inhibition of this particular enzyme in 
response to aqueous potato extracts. The evaluation of 54 different varieties of Chilean 
potato (Solanum tuberosum ssp. tuberosum L.) with varying colors, would also give us an 
idea of how important total phenolic content is in the context of anti-hypertensive 
potentials of a specific varieties. 
 Figure 7, 8 and 9 shows ACE inhibitory activity for aqueous extracts of all potato 
samples. The in vitro ACE inhibitory activity ranged from 0% (PA 2, 9, 14, 15, 20, 22-
27, 29-31, 33, 40, 48-51) to as high as 88% (PA 17). ACE inhibitory activity showed 
high variance for its inhibitions. Low correlation was observed between total phenolics 
and ACE inhibition (r = 0.13). Also, a low correlation was observed between antioxidant 
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 activity by DPPH assay and ACE inhibition (r = 0.21). Correlations observed in this 
study suggest that ACE inhibitory activity does not depend on specific phenolic 
compounds present in potato samples. .Same observation can be true for antioxidant 
activity, because the correlation does not show relevant activity between aqueous extracts 
of DPPH assay and ACE inhibition. Specific phenolic compounds found in potato may be 
able to reduce the risk of hypertension, type II diabetes and other various conditions for 
cardiovascular diseases. It is also possible that bioactive components other than phenolics 
may be responsible for ACE inhibitory activity (Kwon et al., 2006; Pinto et al., 2009). 
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Figure 7 ACE inhibitory activity (% Inhibition) of Chilean Potatoes (Solanum tuberosum 
ssp. tuberosum L.) for samples PA 1-18. 
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Figure 8 ACE inhibitory activity (% Inhibition) of Chilean Potatoes (Solanum tuberosum 
ssp. tuberosum L.) for samples PA 19-36. 
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Figure 9 ACE inhibitory activity (% Inhibition) of Chilean Potatoes (Solanum tuberosum 
ssp. tuberosum L.) for samples PA 38-54. 
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 4.1.5.5 HPLC Analysis of Phenolic Phytochemicals 
 
 Regular intake of natural phenolic compounds through our diet has beneficial 
affects on our overall health through potential reduction of oxidation-linked chronic 
diseases. Aqueous extracts of all samples were analyzed for phenolic profile via HPLC. 
Table 1, 2 and 3 includes data for different compounds found in potatoes. The peaks were 
identified based on retention time and ultraviolet absorption spectra of corresponding 
standards (Pinto et al., 2009). The five phenolic compounds found in the samples 
included chlorogenic acid, ferulic acid, caffeic acid, p-coumaric acid and catechin. 
 Chlorogenic acid is known to contain about 90% of total phenolic compounds of 
potato tubers (Dao and Friedman, 1992), and might play an important role in quality and 
safety of potato plant. Phenolic profile analysis of chlorogenic acid ranged from absence 
(PA 27, 30, 34, 39, 41*, 48) to 17.9 mg/g (PA 8) of sample DW. Chlorogenic acid has the 
ability to lower blood pressure in mildly hypertensive patients, and its derivatives have 
shown to lower blood pressure in hypertensive rats (Cheplick et al., 2010). The phenolic 
compound ferulic acid analyzed in potatoes ranged from absence in some samples (PA 
27, 29, 30, 31, 36, 39, 40, 43, 48, and 52) to 10.5 mg/g (PA 21) of sample DW. Ferulic 
acid has a potential via natural sources to prevent cardiovascular disease and diabetes 
(Zhao et al., 2008). Potato along with eggplant and tomato are good sources of ferulic 
acid, which are shown to supply anywhere from 5-70 mg of ferulic acid/ 100 g (Zhao et 
al., 2008). Caffeic acid was observed to be absent (PA 1, 3, 11, 17*, 36, 51 and 54) to 
10.3 mg/g (PA 42) of sample DW. Caffeic acid has been observed to have beneficial 
potential for managing cardiovascular diseases, as well as its hypotensive affects in 
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 hypertensive rats (Li et al., 2005). Another phenolic compound observed in potato 
samples included p-coumaric acid, which ranged from absent (PA 15, 24-33, 36, 40, 45, 
48 and 54) to 7.3 mg/g (PA 21) of sample DW. The last phenolic compound observed 
was catechin, which ranged from absence 10, 15, 18, 22) to 4.35 mg/g (PA 54) of sample 
DW. Matsui et al. (2007) has suggested that catechin has the potential to prevent diabetes 
through natural intake in our diet. Catechins have heart diseases and cancer prevention 
potential, but another study (Nagao et al., 2007) was carried out to observe its fat 
reducing abilities. Continuous consumption of catechins via our diet, especially in high 
amounts, indicated reduction of fat, cholesterol levels and blood pressure without drastic 
changes in our lifestyles (Nagoa et al., 2007). Therefore, we can assume that inclusion of 
the right sub-tropical cultivars of Chilean potato could be potentially beneficial towards 
our health with potential for prevention of hyperglycemia and hypertension in early 
stages of type II diabetes and associated cardiovascular diseases in the long term. 
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 Table 1 Phenolic Profile (mg/g of sample DW ± Standard Error) Analysis of Chilean 
Potato (Solanum tuberosum ssp. tuberosum L.): Samples 1-18. 
 
SAMPLE 
Chlorogenic 
Acid Ferulic Acid Caffeic Acid P-Coumaric Acid Catechin 
 mg/g DW mg/g DW mg/g DW mg/g DW mg/g DW 
PA 1 13.9 ± 2.99 0.23 ± .003  3.08 ± 0.17 3.08 ± 2.17 
PA 2 14.9 ±  3.72 4.32 ± 0.51 6.77 ± 2.73 0.13 ± .003 0.13 ± 0.09 
PA 3 11.7 ± 3.36 1.18 ± 0.31  1.05 ± 0.40 0.62 ± 0.44 
PA 4 16.5 ± 6.38 1.79 ± 0.39 2.58 ± 0.02 2.16 ± 0.32 1.61 ± 1.14 
PA 5 15.9 ± 4.42 2.27 ± 0.26 1.59 ± 0.05 0.57 ± 0.22 0.96 ± 0.68 
PA 6 13.3 ± 4.17 1.35 ± 0.39 1.12 ± 0.02 0.50 ± 0.10 0.64 ± 0.45 
PA 7 16.2 ± 4.98 0.82 ± 0.27 0.94 ± 0.03 1.87 ± 0.59 1.21 ± 0.85 
PA 8 17.9 ± 5.59 2.20 ± 1.14 0.35 ± .004 1.19 ± 0.54 0.21 ± 0.10 
PA 9 3.50 ± 0.72 1.51 ± 0.50 0.20 ± 0.04 0.12 ± .001 2.49 ± 1.76 
PA 10 2.39 ± 1.16 1.09 ± 0.57 1.85 ± 0.49 1.36 ± .001  
PA 11 19.3 ± 5.12 6.27 ± .006  2.23 ± 0.87 0.71 ± 0.50 
PA 12 15.6 ± 4.29 1.30 ± 0.30 1.34 ± 0.12 1.19 ± 0.18 0.89 ± 0.63 
PA 13 15.5 ± 2.76 4.26 ± 1.42 3.24 ± 0.01 1.82 ± 0.60 0.77 ± 0.55 
PA 14 8.92 ± 2.26 1.81 ± 0.62 1.15 ± 0.20 2.22 ± 0.44 1.44 ± 1.02 
PA 15 4.82 ± 1.33 0.47 ± 0.16 0.83 ± .001   
PA 16 6.86 ± 1.93 1.44 ± 0.26 0.60 ± .001 0.55 ± .007 0.74 ± 0.53 
PA 17 5.95 ± 1.60 1.11 ± 0.36 0.92 ± 0.21 1.40 ± 0.26 0.94 ± 0.66 
PA 17* 6.36 ± 1.39 0.53 ± 0.19  1.37 ± 0.41 1.56 ± 0.78 
PA 18 13.3 ± 2.11 2.28 ± 0.69 1.33 ± 0.46 4.66 ± 0.06  
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 Table 2 Phenolic Profile (mg/g of sample DW ± Standard Error) Analysis of Chilean Potato 
(Solanum tuberosum ssp. tuberosum L.): Samples 19-36. 
 
SAMPLE 
Chlorogenic 
Acid Ferulic Acid Caffeic Acid 
P-Coumaric 
Acid Catechin 
 mg/g DW mg/g DW mg/g DW mg/g DW mg/g DW 
PA 19 6.44 ± 2.51 2.08 ± 0.45 0.91 ± 0.07 1.58 ± 0.41 0.22 ± 0.07 
PA 20 7.23 ± 2.60 1.05 ± 0.38 0.15 ± 0.07 0.36 ± 0.27 0.22 ± 0.08 
PA 21 0.15 ± 0.00 10.5 ± 1.34 3.99 ± 0.74 7.31 ± 2.66 0.43 ± .006 
PA 22 19.6 ± 7.68 3.39 ± 0.19 0.72 ± .004 3.06 ± 1.13  
PA 23 2.11 ± 0.24 0.05 ± 0.01 1.54 ± 0.55 0.14 ± 0.05 0.11 ± 0.04 
PA 24 1.99 ± .002 0.10 ± 0.02 0.86 ± 0.25  0.22 ± 0.09 
PA 25 6.42 ± 2.26 0.71 ± 0.27 1.53 ± 0.54  0.53 ± 0.13 
PA 26 0.09 ± .001 0.15 ± .001 0.16 ± .002  0.54 ± 0.12 
PA 27   0.10 ± 0.01  0.60 ± 0.12 
PA 28 0.21 ± 0.05 0.03 ± .002 0.49 ± .003  1.06 ± 0.14 
PA 29 0.16 ± .001  0.06 ± 0.00  0.80 ± 0.27 
PA 30   0.81 ± 0.19  0.16 ± 0.05 
PA 31 0.07 ± .005  0.19 ± 0.02  1.92 ± 0.57 
PA 32 0.44 ± 0.02 0.16 ± 0.07 2.54 ± 0.03  0.64 ± 0.11 
PA 33 1.53 ± 0.41 0.33 ± 0.07 3.02 ± 0.25  1.71 ± 0.04 
PA 34  0.15 ± 0.06 3.28 ± 0.68 0.18 ± 0.03 2.17 ± 0.16 
PA 35 0.47 ± 0.06 0.18 ± .005 0.51 ± .006  0.07 ± .007 1.05 ± 0.03 
PA 36 3.00 ± 0.54    0.42 ± .002 
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 Table 3 Phenolic Profile (mg/g of sample DW ± Standard Error) Analysis of Chilean Potato 
(Solanum tuberosum ssp. tuberosum L.): Samples 38-54. 
 
SAMPLE Chlorogenic Acid Ferulic Acid Caffeic Acid 
P-Coumaric 
Acid Catechin 
 mg/g DW mg/g DW mg/g DW mg/g DW mg/g DW 
PA 38 1.54 ± 0.49 0.47 ± 0.04 0.95 ± 0.29 0.13 ± .002 0.34 ± 0.18 
PA 39   0.07 ± 0.01 0.04 ± .005 1.03 ± 0.16 
PA 40 1.94 ± 0.01  0.88 ± 0.23  1.45 ± 0.36 
PA 41 3.22 ± 0.06 0.03 ± 0.00 2.07 ± .009 0.05 ± 0.01 1.31 ± 0.45 
PA 41*  0.29 ± 0.11 3.28 ± 0.51 0.04 ± 0.10 1.62 ± 0.48 
PA 42 4.76 ± 1.72 0.86 ± 0.22 10.3 ± 0.11 1.00 ± 0.25 2.73 ± 0.11 
PA 43 1.41 ± 0.48  0.41 ± 0.08 0.03 ± .001 0.87 ± 0.26 
PA 44 1.14 ± 0.29 0.04 ± .007 0.86 ± 0.24 0.66 ± 0.06 2.31 ± 0.20 
PA 45 0.25 ± .003 0.09 ± 0.02 0.80 ± 0.19  1.04 ± 0.24 
PA 46 1.33 ± 0.27 0.14 ± 0.06 4.04 ± 0.83 0.68 ± 0.11 1.55 ± 0.16 
PA 47 0.28 ± .002 0.06 ± 0.01 0.28 ± 0.04 0.13 ± 0.02 1.32 ± 0.16 
PA 48   0.14 ± .006  2.26 ± 0.97 
PA 50 2.46 ± 0.01 0.08 ± .006 2.33 ± 1.06 0.17 ± .002 1.33 ± 0.13 
PA 51 0.61 ± 0.08 0.04 ± .003  0.05 ± .002 4.15 ± 0.84 
PA 52 1.01 ± 0.53  1.58 ± .022 0.03 ± .001 0.98 ± 0.46 
PA 53 0.98 ± .002 0.07 ± .007 0.46 ± 0.02 0.05 ± .005 2.64 ± 0.57 
PA 54 0.53 ± 0.03 0.03 ± .001   4.35 ± 0.72 
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 4.1.6 Conclusions 
 
 In this study, we have evaluated anti-diabetic and anti-hypertensive management 
potential of Chilean Potatoes (Solanum tuberosum ssp. tuberosum L.) linked to type II 
diabetes using in vitro models. We utilized the usual preparation method of potato 
through hot water extraction. Total soluble phenolics, total antioxidant activity by DPPH 
inhibition and functionality assays such as α-glucosidase inhibition, α-amylase inhibition 
and ACE inhibition were also evaluated. The results of this study indicated that Chilean 
potatoes do not have α-amylase inhibitory potential. However, the. α-glucosidase 
inhibition observed show a large variation between all 54 samples. The inhibition ranged 
upto 60%, which indicates that some potato varieties could be considered part of our diet 
to prevent hyperglycemia linked to type II diabetes. Some potato varieties observed 
showed a high ACE inhibition activity, which indicated that specific varieties could be 
potentially beneficial towards prevention of hypertension. This study provides important 
information on functions of several Chilean potato varieties, so appropriate varieties 
could be part of breeding programs and food designs to be part of diets to prevent 
hyperglycemia and hypertension linked to type II diabetes. Based on wide screening 
using in vitro assays and a strong biochemical rationale, specific varieties could be part of 
diet designs for animal and clinical studies.  
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 4.2 Anti-diabetic Potential and Seed Phytochemicals of Select Species of Family 
Apiaceae Using In Vitro Assays 
 
4.2.1 Abstract 
 
 A global epidemic of type II diabetes worsens food-based therapeutic strategies 
for the prevention and management is being explored. Water and 12% ethanol extracts of 
seeds of six select species of family Apiaceae were evaluated for total soluble phenolic 
assay and DPPH inhibition assay. In vitro assays such as α-glucosidase and α-amylase 
inhibition for anti-hyperglycemia potential and angiotensin I-converting enzyme (ACE) 
inhibition for anti-hypertension potential relevant to type II diabetes management were 
evaluated. Total phenolic content for aqueous extracts ranged from 4.8 mg/g (Coriander) 
to 8.3 mg/g (Ajowan) of DW. Total phenolic content and antioxidant activity for aqueous 
extracts indicated a moderate correlation (r = 0.61), and a high correlation (r = 0.73) for 
ethanolic extracts. α-Glucosidase inhibitory activity for aqueous extracts ranged from 
16.5% (Caraway) to 50% (Dill). These in vitro assays indicate that select family 
Apiaceae species used as food condiments have anti-diabetic potentials. This provides the 
biochemical basis for therapeutic strategies for including these condiments as part of 
improved diet for prevention of hyperglycemia and associated hypertension. 
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 4.2.2 Industrial Relevance 
 
 Utilizing plant sources as medicinal food has been widely used throughout the 
world since ancient times. Developing strategies to explore efficacy of plant sources 
towards prevention of hyperglycemia and hypertension linked to type II diabetes would 
serve as the basis for innovation towards industrial applications. This study investigates 
functionalities of seed extracts of select species from family Apiaceae with potential for 
therapeutic and medicinal uses for prevention of hyperglycemia and hypertension linked 
to type II diabetes. This strategy has low toxicity compared to synthetic drugs. Also, 
availability of plant sources in localized communities based on local bioresources for 
disease management is potentially easier and less expensive than synthetic medicines. 
Therefore understanding functionalities of seed sources of family Apiaceae would lead to 
dietary strategies for hyperglycemia and hypertension management, which would be 
available as condiments at a low cost to wider communities globally. 
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 4.2.3 Introduction 
 
 Type II diabetes results from the inability of our body’s to response to high blood 
glucose levels from high carbohydrate diets leading to several metabolic and pathological 
changes. Type II diabetes is one of the most common diseases affecting the people of 
both developed and developing countries, affecting about 5%-7% of the population in 
several countries. The number of people suffering from type II diabetes is believed to be 
rising constantly worldwide and is projected to increase to 400 million by 2030. Plant-
based medicinal drugs have been used for various disease therapies since ancient times. 
Even though there has been a considerable progress in managing type II diabetes through 
synthetic drugs, investigation for natural anti-diabetic plant and food products for its 
management has potential to offer effective less expensive strategies. In addition 
hypoglycemic activities of many plant species have been discovered, acting as anti-
metabolites to help block the oxidation pathway of fatty acids (Ahmad et al., 2009).  
 Plants from family Apiaceae are commonly used as food, flavoring of foods and 
for their medicinal purposes. Seeds from family Apiaceae have been used as a common 
household remedy for many complications such as hypertension (Gilani et al., 2005). 
Plants from Apiaceae family are used in Rajasthan, India to treat common ailments such 
as stomachaches, abdominal pain and acidity (Shekhawat and Batra, 2006). Mixture of 
different plants is consumed orally with water or applied externally through massaging 
abdomen with it (Shekhawat and Batra, 2006). In parts of the world such as Cameroon, 
plants from Apiaceae family are used as therapies for vomiting, appendicitis, ingestion, 
constipation and treating mosquito bites (Jiofack et al., 2009). 
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  Ancient form of Indian medicine ‘Ayurveda’ uses the active ingredients from 
plants for treatment of various diseases (Dhandapani et al., 2002). Compared to synthetic 
drugs, plant products are less toxic and have less of side effects. Plants from Apiaceae 
family are frequently considered to have hypoglycemic affects on humans and animals 
(Dhandapani et al., 2002). Hypoglycemic action of plants are due to insulin effect by 
increasing pancreatic secretion of insulin from cells of islets of Langerhan’s or its release 
from bound insulin (Dhandapani et al., 2002). 
 Additionally other seed extracts from Apiaceae family have been observed for 
their health beneficial effects. Essential oils from Foeniculum vulgare seeds (Fennel) 
such as anethole and limonene are used for medicinal purposes and their seeds are also 
used as tranquillizers and tonics (Oktay et al., 2003). Aqueous extracts of fennel are 
observed for its hypotensive effect in a dose-related manner (Oktay et al., 2003). 
Anethum graveolens seed (Dill) extracts are used to treat diarrhea and scours as well as 
feeding it to goats and cows for enhancing milk production (Lans et al., 2007). 
Coriandrum sativum seeds (Coriander) are mainly used as food flavoring agent and also 
used to treat ulcers (Husain et al., 2008). Trachyspermum copticum (Ajowan) seeds are 
frequently used to treat diarrhea, ingestion and common colds. Ajowan seed oils are 
suggested to treat medical problems affecting joints or painful muscle conditions (Husain 
et al., 2008). Carum carvi (Caraway) is suggested to have beneficial effects for treatment 
and management of diabetes and cardiovascular diseases. It evokes beneficial effects on 
the elevation of lipids in the bloodstream associated with hyperglycemia (Lemhadri et al., 
2006). Pimpinella anisum (Anise) is a plant belonging to Apiaceae family native to the 
Middle East which is used as aromatic spice and to help digestion (Arslan et al., 2004).   
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  Understanding the biochemical basis for medicinal uses and phytotherapies of 
Apiaceae family with a focus on their seeds would provide us with a basis for further 
clinical research which will provide insight on how they could be targeted towards 
prevention of certain chronic diseases. Plant-based medicinal treatments for targeted 
prevention of diabetes and other diseases are going to play an important part due to its 
low toxicity potentials and low cost for wide usage. In this study, we have investigated 
functionalities of seeds of 6 select species of family Apiaceae, and how their in vitro 
effects could provide a biochemical rationale to potentially target them towards the 
prevention and management of hyperglycemia and hypertension linked to type II 
diabetes. We evaluated total soluble phenolics and DPPH inhibition assay to determine 
total antioxidant activity and used High Performance Liquid Chromatography for analysis 
of phenolic phytochemicals of seeds. In vitro assays such as α-glucosidase, α-amylase 
and angiotensin converting enzyme (ACE) inhibitory activities were performed to 
evaluate seeds potential towards hyperglycemia and hypertension management as part of 
dietary strategies for management of type II diabetes and its complications. 
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 4.2.4  Materials and Methods 
 
4.2.4.1 Materials 
 
Apiaceae family seeds were Swad brand dill, ajowan, fennel, coriander and anise 
were purchased from a local Asian grocery store (Asian-American International) in 
Hadley, MA, USA. Caraway sample evaluated was purchased from Whole Foods Market 
Hadley, MA, USA. Porcine pancreatic α-amylase (EC 3.2.1.1), rat intestinal α-
glucosidase (EC 3.2.1.20), hippuric acid, 2,2-diphenyl-1-picrylhydrazyl (DPPH), rabbit 
lung ACE (EC 3.4.15.1), cinnamic acid, rosmarinic acid, protocatechuic acid, p-coumaric 
acid, chlorogenic acid, caffeic acid, ferulic acid, and quercetin were purchased from 
Sigma Chemical Co. (St. Louis, MO). 
 
4.2.4.2 Sample Preparation 
 
Water Extracts:  
 The samples (2.5 g) were extracted in 100 mL of distilled water under reflux at 
95°C for 30 minutes. The samples were centrifuged for 10 minutes.  
 
Ethanol extracts:  
 The samples (2.5 g) were extracted in 100 mL of 12% ethanol in a shaker at a 
speed of 150 RPM overnight at 20°C. The samples were filtered and stored in a 
refrigerator at –20°C until analysis, for no more than 1 week. 
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 4.2.4.3 Total Soluble Phenolic Assay 
 
The total phenolics in all samples were determined by using a method modified 
by Shetty et al. (1995). In brief; 0.5 ml of sample extract was added to a test tube and 
mixed with 0.5 mL of 95% ethanol and 5 mL of distilled water. To each sample, 0.5 mL 
of 50% (vol/vol) Folin-Ciocalteu reagent was added and mixed. The absorbance was read 
at 725 nm using a spectrophotometer (Genesys UV/Visible, Milton Roy, Inc., Rochester, 
NY). Different concentrations of gallic acid were used to develop a standard curve. 
Results were expressed as mg of gallic acid/g of sample dry weight (DW). 
 
4.2.4.4 Total Antioxidant activity by DPPH Radical Inhibition Assay 
 
The antioxidant activity was determined by the DPPH radical scavenging method 
modified from Kwon et al. (2006). A 250-μL aliquot of the sample extract was mixed 
with 1,250 μL of DPPH (60 μM in ethanol). The mixture was centrifuged at 13,000 g for 
1 minute, and after this the absorbance was measured at 517 nm using the Genesys 
UV/Visible spectrophotometer. The readings were compared with the controls, 
containing 95% ethanol instead of sample extract. The percentage inhibition was 
calculated by: 
 
% inhibition =  (Absorbancecontrol − Absorbanceextract )
Absorbancecontrol
×100 
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 4.2.4.5 α-Amylase Inhibition Assay 
 
 The α-amylase inhibitory activity was determined by an assay modified from the 
Worthington Enzyme Manual (Worthington, 1993). A total of 500 µL of sample extract 
and 500 µL of 0.02 M sodium phosphate buffer (pH 6.9 with 0.006 M NaCl) containing 
α-amylase solution (0.5 mg/mL) were incubated at 25°C for 10 minutes. After 
preincubation, 500 µL of a 1% starch solution in 0.02 M sodium phosphate buffer (pH 
6.9 with 0.006 M NaCl) was added to each tube at timed intervals. The reaction was 
stopped with 1.0 mL of dinitrosalicylic acid color reagent. The test tubes were incubated 
in a boiling water bath for 5 minutes and cooled to room temperature. The reaction 
mixture was then diluted after adding 5-15 mL of distilled water, and the absorbance was 
measured at 540 nm using the Genesys UV/Visible spectrophotometer. The readings 
were compared with the controls, containing buffer instead of sample extract. The 
percentage α-amylase inhibitory activity was calculated with the same equation as for 
percentage inhibition in the DPPH radical inhibition assay.  
 
4.2.4.6 α-Glucosidase Inhibition Assay 
 
The α-glucosidase inhibitory activity was determined by an assay modified 
from McCue et al. (2005). α-Glucosidase was assayed by using 50 μL of sample extracts 
and 100 μL of 0.1 M phosphate buffer (pH 6.9) containing α-glucosidase solution (1 
U/mL) and was incubated in 96-well plates at 25°C for 10 min. After preincubation, 50 
μL of 5 mM p-nitrophenyl-α-d-glucopyranoside solution in 0.1 M phosphate buffer (pH 
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 6.9) was added to each well at timed intervals. The reaction mixtures were incubated at 
25°C for 5 min. Before and after incubation, absorbance readings were recorded at 405 
nm by a microplate reader (Thermomax, Molecular Devices Co., Sunnyvale, CA) and 
compared to a control that had 50 μL of buffer solution in place of the extract. The α-
glucosidase inhibitory activity was expressed as percentage inhibition and was calculated 
with the same equation as for percentage inhibition in the DPPH radical inhibition assay. 
Dose dependency was tested using 25 µl and 10 µl of the sample, the volume made up to 
50 µl using 0.1 M phosphate buffer (pH 6.9) and same protocol was followed. 
 
4.2.4.7 ACE Inhibition Assay 
 
ACE inhibition was assayed by a method modified by Kwon et al. (2006). The 
substrate hippuryl-histidyl-leucine (HHL) and the enzyme ACE-I from rabbit lung (EC 
3.4.15.1) were used. Fifty μL of sample extracts were incubated with 100 μL of 1 M 
NaCl-borate buffer (pH 8.3) containing 2 mU of ACE-I solution at 37°C for 10 min. 
After preincubation, 100 μL of a 5 mU substrate (HHL) solution was added to the 
reaction mixture. Test solutions were incubated at 37°C for 1 hour. The reaction was 
stopped with 150 μL of 0.5 N HCl. Five μL of the sample was injected in a high-
performance liquid chromatography (HPLC) apparatus (Agilent 1100 series equipped 
with autosampler and DAD 1100 diode array detector, Agilent Technologies, Palo Alto, 
CA). The solvents used for gradient were (1) 10 mM phosphoric acid (pH 2.5) and (2) 
100% methanol. The methanol concentration was increased to 60% for the first 8 min and 
to 100% for 5 min and then was decreased to 0% for the next 5 min (total run time, 18 
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 min). The analytical column used was an Agilent Nucleosil 100-5C18, 250 mm × 4.6 mm 
inside diameter, with packing material of 5 μm particle size at a flow rate of 1 mL/min at 
ambient temperature. During each run, the absorbance was recorded at 228 nm, and the 
chromatogram was integrated using the Agilent Chemstation (Agilent Technologies) 
enhanced integrator for detection of liberated hippuric acid (A). Hippuric acid standard 
was used to calibrate the standard curve and retention time. The percentage inhibition 
was calculated by: 
% inhibition =  (Acontrol − Aextract )
(Acontrol − Ablank )
×100
 
 
4.2.4.8 HPLC Analysis of Phenolic Phytochemicals 
 
Two milliliters of the extracts was filtered (pore size, 0.2 μm), and 5 μL was 
injected in the HPLC apparatus (Agilent 1100 series equipped with autosampler and 
DAD 1100 diode array detector). The solvents used for gradient elution were (A) 10 mM 
phosphoric acid (pH 2.5) and (B) 100% methanol. The methanol concentration was 
increased to 60% for the first 8 minutes and to 100% over the next 7 minutes, then 
decreased to 0% for the next 3 minutes, and maintained for the next 7 minutes (total run 
time, 25 minutes). The analytical column used was an Agilent Zorbax SB-C18, 250 mm 
× 4.6 mm i.d., with packing material of 5 μm particle size at a flow rate of 1 mL/minute 
at ambient temperature. During each run the absorbance was recorded at 306 nm and 333 
nm, and the chromatogram was integrated using the Agilent Chemstation enhanced 
integrator. Calibration was performed by injecting the standards of cinnamic acid, 
rosmarinic acid, protocatechuic acid, p-coumaric acid, chlorogenic acid, caffeic acid, 
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 ferulic acid, and quercetin. Peak identification was performed by comparison of retention 
times and diode array spectral characteristics with the standards. The results were 
expressed as μg/g of sample DW. 
 
4.2.4.9 Statistical Analysis 
 
All experiments were performed in either duplicates or triplicates. Analysis at 
every time point from each experiment was carried out in duplicate or triplicate. Means, 
standard errors and standard deviations were calculated from replicates within the 
experiments and analyzed using Microsoft Excel XP. 
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 4.2.5 Results and Discussion 
  
4.2.5.1 Total Soluble Phenolics and Total Antioxidant Activity by DPPH 
 
 In this study, we focused on aqueous and ethanolic extracts from seeds of six 
different species from the family Apiaceae, to screen their anti-hyperglycemia and anti-
hypertension potentials using in vitro assays. Figure 10 shows the total phenolic content 
of aqueous seed extracts. Total phenolic content for these samples ranged from 4.8 mg/g 
(Coriander) to 8.3 mg/g (Ajowan) of sample DW. Figure 11 shows total phenolic content 
of ethanolic extracts, which ranged from 2.42 mg/g (Caraway) to 8 mg/g (Ajowan) of 
sample DW. Plant phenolic content is known to be linked to therapeutic potential for use 
in prevention and management of type II diabetes. Medicinal plant species observed in 
this study could be considered a good source of polyphenols due to their high total 
phenolic content (Kesilova et al., 2006), and related total antioxidant activity. The 
moderate and high correlations in this study suggest that, high antioxidant potential 
varied for each species. 
 Figure 10 shows results for antioxidant activity by DPPH assay for aqueous 
extracts. In vitro antioxidant activity measured by DPPH assay for aqueous extracts 
ranged from 62.8% (Caraway) to 76.5% (Dill). Total phenolic content of aqueous 
samples indicated a moderate correlation (r = 0.61) with antioxidant activity by DPPH 
assay. Addition of antioxidants to the diet has potential for slowing down oxidation of 
fats (Yen and Duh, 1994), and can be identified as free radical or active oxygen 
scavengers (Oktay el al., 2003). Therefore, high DPPH inhibition observed for aqueous 
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 extracts suggest that inclusion of these seed ingredients from food condiment sources in 
our diet could have relevance for combating chronic oxidation-linked metabolic pathways 
associated with high calorie diet and associated obesity. This could potentially serve as an 
important factor for controlling obesity which is linked to the incidence of type II 
diabetes.  
 Figure 11 shows the results of ethanolic extracts for all samples, which ranged 
from 25.1% (Coriander) to 68.7% (Ajowan). Total phenolic content of ethanolic extracts 
had a high correlation (r = 0.73) with antioxidant activity by DPPH.  This high 
correlation suggests that the amount of antioxidants in ethanolic extracts is due to the 
phenolic content of plant species as suggested by Kesilova et al. (2006) and many other 
studies. Specific species with high antioxidant activity from family Apiaceae such as dill 
and ajowan could be part of food preparation as condiments in foods for managing 
chronic disease states or even as medicinal material for replacing synthetic antioxidants. 
Synthetic antioxidants are also being restricted due to their carcinogenicity (Zheng and 
Wang, 2001), and natural antioxidants have the capability of both preserving food, 
adding flavor and potentially protecting human body from free radicals and associated 
chronic diseases (Oktay et al., 2003). 
 
 
 
 
                                                                       68
 0
1
2
3
4
5
6
7
8
9
10
Dill Ajowan Fennel Caraway Coriander Anise
Sample
To
ta
l S
ol
ub
le
 P
he
no
lic
s 
(m
g 
G
AE
/ g
 D
W
)
0
10
20
30
40
50
60
70
80
90
100
%
 D
PP
H 
In
hi
bi
tio
n
Total Soluble Phenolics
DPPH
 
Figure 10 Total Soluble Phenolics (mg GAE/ g DW ± Standard Error) and Total 
Antioxidant Activity (% DPPH Inhibition ± Standard Error) correlation of aqueous 
extracts of Dill, Ajowan, Fennel, Caraway, Coriander and Anise. 
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Figure 11 Total Soluble Phenolics (mg GAE/ g DW ± Standard Error) and Total 
Antioxidant Activity (% DPPH Inhibition ± Standard Error) correlation of ethanolic 
extracts of Dill, Ajowan, Fennel, Caraway, Coriander and Anise. 
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 4.2.5.2 α-Glucosidase Inhibition 
 
 Dose dependency studies (10µL, 25µL, 50µL) for the 6 species of family 
Apiaceae demonstrated dose dependent responses. Figure 12 illustrates the results for 
aqueous extracts, which ranged from 0% inhibition (Coriander and Anise) to almost 50% 
inhibition (Dill). The total phenolic content for aqueous extracts showed a high 
correlation (r = 0.86) with α-glucosidase inhibition. Also, the total phenolic content for 
ethanolic extracts showed a high correlation (r = 0.76) with α-glucosidase inhibition. 
Natural herbal medicines have been targeted all over the world for prevention of high 
blood pressure and type II diabetes (Loizzo et al., 2008). α-Glucosidase inhibition results 
from this study suggest that family Apiaceae consists of certain hypoglycemic bioactive 
compounds. This inhibition of digestive enzyme α-glucosidase would delay the 
degradation of oligosaccharides, which would decrease the absorption of glucose 
inhibiting the increase in postprandial hyperglycemia (Loizzo et al., 2008). High 
antioxidant activity and total phenolic content appeared to be a good predictor of α-
glucosidase inhibition because of its high correlation for aqueous extracts. Therefore 
condiments with high α-glucosidase inhibition such as Dill and Ajowan could be used as 
condiment target species from family Apiaceae to be part of dietary management of 
hyperglycemia linked to type II diabetes. 
 Figure 13 shows the results of α-glucosidase inhibition for ethanolic extracts. 
Unlike aqueous extracts, where samples Coriander and Anise showed no inhibition, for 
ethanolic extracts there was some inhibition for all 6 samples. α-Glucosidase inhibition 
for ethanolic extracts ranged from 1.7% (Anise) to 32% (Ajowan). Antioxidant activity 
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 for aqueous extracts showed a low correlation (r = 0.48) with α-glucosidase inhibition. In 
terms of antioxidant activity ethanolic extracts showed a moderate correlation (r = 0.55) 
with α-glucosidase inhibition. Overall, α-glucosidase inhibition observed for ethanolic 
extracts is lower than aqueous extracts, but suggests that they still contain hypoglycemic 
bioactive compounds required for potentially managing hyperglycemia. We suspect that 
higher inhibition of aqueous extracts could be a more natural way of preparing food, and 
preparation with hot water might be more efficient for the outcome to naturally reach 
digestive enzymes to manage hyperglycemia. Based on these results, seed sources of 
plant species such as family Apiaceae has the potential for anti-diabetic activity which 
could prove to be effective as the clinical agents when consumed in small doses on a 
consistent basis through the diet. Overall high antioxidant activity and total phenolic 
content did not prove to be a good indicator of α-glucosidase inhibition because of low to 
moderate correlations for both aqueous and ethanol extracts. 
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Figure 12 Changes observed in dose dependent (10 µL, 25 µL, 50 µL) % α-glucosidase 
inhibitory activities for aqueous extracts of Dill, Ajowan, Fennel, Caraway, Coriander 
and Anise.  
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Figure 13 Changes observed in dose dependent (10 µL, 25 µL, 50 µL) % α-glucosidase 
inhibitory activities for ethanolic extracts of Dill, Ajowan, Fennel, Caraway, Coriander 
and Anise.  
 
 
4.2.5.3 α- Amylase Inhibition 
 
 Dose dependency studies (10µl, 25µ1, 50µl) allowed us to observe dose 
dependent responses for the 6 species of family Apiaceae. Figure 14 shows results for 
aqueous extracts, which were in the range from 0% (Ajowan) to 32% (Caraway). Total 
phenolic content for aqueous extracts demonstrated an inverse correlation (r = -0.54) 
with α-amylase inhibition. Also, phenolic content for ethanolic extracts showed an 
inverse correlation (r = -0.66) with α- amylase inhibition. Above correlations observed, 
indicated that total phenolic content has no influence on α-amylase inhibition. Previous 
studies have suggested that α-amylase inhibition is not linked to high antioxidant activity 
or total phenolics content (Cheplick et al., 2010).  
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  Aqueous extracts for samples of this study indicate a slightly higher inhibition 
than ethanolic extracts. Even though α-amylase inhibition is considered to have positive 
affects on prevention of hyperglycemia linked to type II diabetes, excess α- amylase 
inhibition could lead to stomach distention and discomfort (Puls et al., 1977; Cheplick et 
al., 2010). Moderate α-amylase inhibition and good α-glucosidase inhibition makes 
family Apiaceae species good candidates for managing early stage hyperglycemia linked 
to type II diabetes. 
 Figure 15 shows results for ethanolic extracts, which ranged from 0% (Ajowan) to 
30% (Coriander). Antioxidant activity for aqueous extracts showed an inverse correlation 
(r = -0.54) with α-amylase inhibition. Also, antioxidant activity for ethanolic extracts 
demonstrated an inverse correlation (r = -0.66) with α-amylase inhibition. Correlations 
between α-amylase and DPPH inhibition suggest that, total antioxidant activity does not 
reflect the potential for α-amylase inhibition. This indicates that overall phenolic 
antioxidants do not play any role in determining α-amylase inhibitory potential. It is also 
possible that specific phenolics not present in species of family Apiaceae studied maybe 
responsible or as suggested in previous studies (Kwon et al., 2006; Cheplick et al., 2010) 
non-phenolic bioactives may be responsible. In general, managing hyperglycemia linked 
to type II diabetes can be targeted through moderate α-amylase inhibition along with α-
glucosidase inhibition (Pinto et al., 2008). Therefore, Apiaceae family species such as 
Dill and Ajowan might be considered good candidates for further in vivo studies to gain a 
better insight on managing early stage hyperglycemia linked to type II diabetes. α-
Amylase inhibition of family Apiaceae, such as Dill and Caraway in aqueous and 
ethanolic extracts also have potential of controlling blood glucose level in the context of 
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 preventing and managing type II diabetes through combinations of these condiments with 
other whole foods with similar bioactive properties as in the case of Chilean potatoes. 
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Figure 14 Changes observed in dose dependent (10 µL, 25 µL, 50 µL)) % α-amylase 
inhibitory activities for aqueous extracts of Dill, Ajowan, Fennel, Caraway, Coriander 
and Anise. 
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Figure 15 Changes observed in dose dependent (10 µL, 25 µL, 50 µL)) % α-amylase 
inhibitory activities for ethanolic extracts of Dill, Ajowan, Fennel, Caraway, Coriander 
and Anise. 
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 4.2.5.4 ACE Inhibition  
 
 Hypertension is known to be a risk factor of various cardiovascular diseases and 
is associated with long term diabetes (Kwon et al., 2006). In this study, we did not 
observe ACE inhibitory activity for neither aqueous nor ethanolic extracts for family 
Apiaceae. We suspect that, reason behind lack of ACE inhibition could be the use of 
smaller amount of sample (2.5 g) to prepare extracts. 
 
4.2.5.5 HPLC Analysis of Phenolic Phytochemicals 
 
 We observed 8 phenolic compounds in 6 selected species of family Apiaceae 
based on the phenolic profile analysis using HPLC. The 8 phenolic compounds observed 
include caffeic acid, catechin, rutin, chlorogenic acid, gallic acid, ferulic acid and 
rosmarinic acid. The amounts (mg/g DW) and their standard error values are presented in 
Table 4 and 5 for water and ethanol extracts. The content of caffeic acid in aqueous 
extracts ranged from 0 mg/g (Coriander and Anise) to 3.93 mg/g (Fennel) of sample DW. 
Caffeic acid in ethanolic extracts ranged from 0 mg/g (Dill and Ajowan) to 5.53 mg/g 
(Anise) of sample DW. These results suggest that ethanolic and aqueous extracts have 
specific phenolics in different species and in specific cases higher in ethanolic extracts. 
Anise seeds do not have any bioactive caffeic acid in aqueous extract (0 mg/g DW) but 
has higher content in its ethanolic extract (5.53 mg/g DW). Caffeic acid is known to be 
naturally present in fruits and vegetables, and has anti-inflammatory and anti-oxidative 
properties (Son and Lewis, 2002). Therefore, we can relate the actions of caffeic acid to 
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 potentially help manage chronic oxidative diseases such as type II diabetes and 
cardiovascular diseases.  
 The catechin content in aqueous extracts of various samples ranged from 0 mg/g 
(Fennel, Caraway, Coriander and Anise) to 2.23 mg/g (Ajowan) of sample DW. Catechin 
activity for ethanolic extracts ranged from 0 mg/g (Fennel, Caraway and Anise) to 1.26 
mg/g (Ajowan) of sample DW.  Affect of catechin on human health has attracted 
attention due to its antioxidant potential. It has been shown that ingestion of catechins is 
known to decrease waist size while reducing body fat (Nagao et al., 2007). Even though 
the amount of catechin observed is low, specific species from family Apiaceae has 
potential of affecting energy and fat metabolism when incorporated in diet designs on 
consistent basis along with other legumes, fruits and vegetables containing catechins. 
 The content of rutin in aqueous extracts ranged from 0 mg/g (Caraway and Anise) 
to 27.6 mg/g (Dill) of sample DW. Rutin content in ethanolic extracts ranged from 0 
mg/g (Fennel, Caraway and Anise) to 17.8 mg/g (Dill) of sample DW. The content of 
Dill is the highest of any phenolic compounds found in the current study. Rutin is known 
to have affects on dilating blood vessels and improving interpenetration of veins (Wang 
et al., 2003). Rutin is found in many plants and is reported to have anti-inflammatory and 
antioxidant activities. Rutin’s antioxidant activity is known to be responsible for many of 
its bioactive activities (La Casa et al., 2000), such as preventing oxidative stress in 
pancreatic beta cells which could lead to uncontrolled proliferation of damaged 
pancreatic beta cells, increasing diabetes risk (Heineke et al., 1993). High amount of rutin 
present in Dill species leads to the conclusion that, these samples could prove to have 
protective affects against the development of type II diabetes and further in vivo studies 
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 would be needed based on incorporation of such condiments in a range of whole foods, 
including potato and starch foods such as bread. 
 The content of chlorogenic acid in aqueous extracts ranged from 0 mg/g (Dill, 
Ajowan and Anise) to 4.71 mg/g (Coriander) of sample DW. Chlorogenic acid content in 
ethanolic extracts was only observed for anise, which was 2.78 mg/g of sample DW. 
Chlorogenic acid is an antioxidant and potentially contributes in the prevention of 
cardiovascular diseases and type II diabetes. The content of gallic acid was observed in 
Caraway and Anise for aqueous extracts, which were 0.13 mg/g and 0.09 mg/g of sample 
DW, respectively. The content of gallic acid in Caraway and Coriander for ethanolic 
extracts was 1.02 mg/g and 0.55 mg/g of sample DW, respectively. Higher content of 
gallic acid was found in ethanolic extracts of Caraway and Coriander than aqueous 
extracts, but in general, a higher overall concentration was observed in aqueous extracts 
of other species in this study. The content of p-coumaric acid and ferulic acid was very 
low as indicated in Table 5. The content of rosmarinic acid in aqueous extracts ranged 
from 0 mg/g (Fennel and Coriander) to 7.08 mg/g (Ajowan) of sample DW. The content 
of rosmarinic acid in ethanolic extracts ranged from 0 mg/g (Caraway and Coriander) to 
7.18 mg/g (Dill) of sample DW. Rosmarinic acid is a well known bioactive phenolic 
compound targeted against oxidation-linked diseases (Shetty, 1997; Shetty and 
Wahlqvist, 2004).   
 Presence of all the above phenolic compounds in seeds suggests that select 
species of family Apiaceae in aqueous and ethanolic extracts have ability to provide 
protection against oxidation-linked diseases. Such seed ingredients in whole food form 
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 can be used as condiments with a range of food designs for better dietary management of 
hyperglycemia linked to type II diabetes. 
 
Table 4 Phenolic Profile (mg/g of sample DW ± Standard Error) Analysis of Family 
Apiaceae for Aqueous and Ethanolic Extracts. Analysis of Phenolic Compounds: Caffeic 
Acid, Catechin, Rutin and Chlorogenic Acid. 
 
Sample Caffeic Acid Catechin Rutin 
Chlorogenic 
Acid 
 mg/g DW 
 
mg/g DW mg/g DW 
H2O     
Dill 1.62 ± 0.10 2.22 ± 0.14 27.6 ± 1.84  
Ajowan 1.14 ± 0.03 2.23 ± 0.03 4.00 ± 0.52  
Fennel 3.93 ± 0.03  5.37 ± 0.04 4.69 ± 0.03 
Caraway 0.69 ± 0.02   2.99 ± 0.01 
Coriander   5.50 ± 0.15 4.71 ± 0.06 
Anise     
     
ETHANOL     
Dill  1.12 ± 0.40 17.8 ± 6.20  
Ajowan  1.26 ± 0.23 3.26 ± 0.86  
Fennel 1.56 ± 0.121    
Caraway 0.88 ± 0.00    
Coriander 0.90 ± 0.33 0.13 ± 0.00 1.25 ± 0.11  
Anise 5.53 ± 2.07   2.78 ± 0.00 
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 Table 5 Phenolic Profile (mg/g of sample DW ± Standard Error) Analysis of Family 
Apiaceae for Aqueous and Ethanolic Extracts. Analysis of Phenolic Compounds: Gallic 
Acid, P-coumaric Acid, Ferulic Acid and Rosmarinic Acid. 
 
Sample Gallic Acid p-coumaric acid Ferulic Acid Rosmarinic Acid 
 mg/g DW mg/g DW mg/g DW mg/g DW 
H2O     
Dill    2.96 ± 0.18 
Ajowan    7.08 ± 3.92 
Fennel     
Caraway 0.13 ± 0.00   1.09 ± 0.31 
Coriander  0.15 ± 0.01 1.98 ± 0.03  
Anise 0.09 ± 0.01   2.84 ± 0.00 
     
ETHANOL     
Dill    7.18 ± 0.00 
Ajowan    2.32 ± 0.49 
Fennel    1.65 ± 0.00 
Caraway 1.02 ± 0.48 0.11 ± 0.00 
  
Coriander 0.55 ± 0.03 0.24 ± 0.00 0.69 ± 0.00  
Anise  0.82 ± 0.00  5.54 ± 1.74 
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 4.2.6 Conclusions 
 
 In this study, we have evaluated phenolic-linked anti-hyperglycemia potential of 
seed phytochemicals of 6 select species of family Apiaceae with relevance for dietary 
management of type II diabetes. Hot water and 12% ethanol extraction methods were 
utilized to prepare samples used for further evaluation of their functionalities, using in 
vitro assays. Total Soluble Phenolics, DPPH inhibition assay, α-glucosidase inhibition, α-
amylase inhibition and ACE inhibition were evaluated. Results indicated that there was 
no ACE inhibition in any of the 6 selected species of family Apiaceae. α-Glucosidase 
inhibition ranged upto 50%, and showed a large variation among samples. This 
observation indicates that including Apiaceae family species in our diet would have 
potential to manage hyperglycemia contributing potentially to overall prevention and 
management of type II diabetes. Further, α-amylase inhibition was observed upto 30%, in 
some species which indicates that select species from Apiaceae family could be helpful 
towards controlling blood glucose levels preventing hyperglycemia. This research study 
provides in vitro biochemical rationale of disease-linked functions of select seed 
phytochemicals of the family Apiaceae, which provides the structure-function basis for in 
vivo experiments for development of therapeutic strategies to help prevent chronic 
hyperglycemia and associated complications linked to management of type II diabetes. 
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 4.3 Anti-Diabetic Potential of Select Middle Eastern Herbs of Family Lamiaceae 
Using In Vitro Assays 
 
4.3.1 Abstract 
 
 Emerging global trends indicate the use of bioactive compounds from plants as 
sources of food and medicine for prevention and management of type II diabetes. In this 
study, we screened 2 plant species of Lamiaceae family from the Near East Asia for its 
total phenolic content and total antioxidant activity. In vitro functionality assays were 
used to screen for α-glucosidase, α-amylase and angiotensin converting enzyme (ACE) 
inhibitory activities to explore the biochemical relevance for management of 
hyperglycemia and hypertension. Aqueous extracts of marjoram (41.1 mg/g DW) and 
sage (38.4 mg/g DW) had higher total phenolic content compared to ethanolic extracts of 
22.1 mg/g (Marjoram) and 16.7 mg/g (Sage). High α-glucosidase inhibitory activity was 
observed for aqueous extracts of marjoram (86%) and sage (77%). High α-glucosidase 
inhibition suggests that species from Lamiaceae family has potential to manage 
hyperglycemia linked to type II diabetes. 
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 4.3.2 Introduction 
 
 Type II diabetes is considered as one of the most common metabolic disorders 
worldwide and management of this epidemic is now targeting wide range of plants used 
in food and medicine from local bioresources. Today, as many as 80% of the world 
population relies on using traditional medicine for healthcare purposes (Muthu et al., 
2006). In the Middle East, wild edible plants have been used as a source of food and 
medicine since ancient times. People from the Middle Eastern origin believe there is a 
strong relationship between food and medicine (Dogan et al., 2004). Natural α-amylase 
and α-glucosidase inhibitors from food grade plants offer cost effective and locally based 
strategies to control postprandial hyperglycemia, and these inhibitors could be used in 
therapies with minimum side effects (Kwon et al., 2006; Pinto et al., 2009). Plant sources 
used as medicinal herbs have good potential over synthetic drugs due to low toxicity of 
plants (Kwon et al., 2006). 
 Herbs are a rich source of phenolic phytochemicals having high antioxidant 
activity (Kwon et al., 2006). High phenolic antioxidants from plants are highly correlated 
with natural α-glucosidase inhibitors, and its presence increases the potential for 
preventing hyperglycemia linked to on-set of type II diabetes. Plants such as Origanum 
majorana (Marjoram) and Salvia libanotica (Sage) belongs to Lamiaceae family (Mint 
Family), which also includes other plants such as rosemary and lavenders. Plants from 
Lamiaceae family have commonly been used for food preservation, culinary flavors and 
for treating common illnesses as traditional medicine (Shetty, 1997; Kwon et al., 2006). 
Many plants and herbs related to Lamiaceae family have originated from the Middle East 
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 region in Asia. Lamiaceae family has aromatic characteristics and most of them are 
grown for their essential oil producing tendencies. These herbs contain phenolic 
phytochemicals, having therapeutic properties that are beneficial towards human health 
(Shetty, 1997). Phenolic phytochemicals are associated with having potential for 
managing chronic oxidation linked diseases, such as cardiovascular diseases and diabetes 
(Shetty, 1997; Pinto and Shetty, 2010). Also, phytochemicals contain significant 
antioxidant capacities which have potential to lower mortality rates of cancer in human 
populations (Veioglu et al., 1998). 
  Free radicals play an important role in developing tissue damage in several 
diseases such as metabolic syndrome diseases, cancer, neurodegenerative diseases and 
pathological disorders (Erdemoglu et al., 2006). Antioxidants are known to play a crucial 
part in prevention of many such diseases. Antioxidants inhibit the oxidation of lipids, by 
inhibiting the propagation of oxidative chain reactions (Javanmardi et al., 2003). 
Medicinal plants and herbs such as those species in the family Lamiaceae are an excellent 
source of natural antioxidants used as spices and aromatic herbs. In particular, plants such 
as sage, marjoram, thyme and rosemary are known to have strong antioxidant activity. 
Salvia is the genera of plants that is considered one of the most diverse in Turkey with 
many species, and has been used as traditional medicine to treat common colds and 
stomach disorders (Cuvelier et al., 1996). Water extracts of sage are commonly used in 
the Middle East to treat common colds, coughs and as anti-inflammatory agent in oral 
cavity (Farhat et al., 2001). Studies have shown that essential oils of this plant has 
antibacterial effects, as well as suppressive activities against tumor formation (Hilan et 
al., 1997; Farhat et al., 2001) Origanum majorana commonly known as marjoram, is also 
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 rich in essential oils and also characterized with high content of phenolic compounds. 
Marjoram is commonly used in the Middle East as folk medicine, particularly in the form 
of tea as a prescription for fever, sinus congestion and nervous disorders (Qari, 2008). 
Marjoram is known for its potent antioxidant and antimicrobial activities similar to sage. 
Marjoram consists of anti-hepatoma and anti-genotoxicity activities, based on the 
indication that it reduces number of cell and chromosomal aberrations (Qari, 2008). 
These characteristics of marjoram could play an important preventive role in occurrence 
of type II diabetes. Pancreatic beta cells could be damaged due to oxidative stress before 
they are replicated or proliferated. If damaged pancreatic beta cells are prevented from 
proliferating through cell repair and apoptosis, then the possibility of incidence of 
diabetes from occurring could be reduced. Therefore, the inclusion of herbal food sources 
in our diet could help manage hyperglycemia in early stages which is linked to long term 
diabetes from further defects in pancreatic cells from hyperglycemia-linked oxidative 
damage. 
 Therefore the objective of this research study was to screen 2 species belonging to 
Lamiaceae family from the Near East Asia region for their total phenolic content and 
total antioxidant activity. Following these studies, in vitro assays such as α-amylase, α-
glucosidase and ACE inhibitory activities were evaluated. These in vitro assays would 
provide biochemical rationale for use of sage and marjoram in prevention of 
hyperglycemia and hypertension linked to type II diabetes. Also, we determined 
individual phenolic compounds found in phenolic profile by HPLC. This would allow us 
to correlate phenolic compounds of herbs to total antioxidant activity and total soluble 
phenolics content and link it to specific health relevant functional activity. 
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 4.3.3 Materials and Methods 
 
4.3.3.1 Materials 
 
Dried herb sample of Origanum majorana (Marjoram) and Salvia libanotica 
(Sage) were obtained from the Department of Biology of United Arab Emirates 
University, Al-Ain, UAE. Porcine pancreatic α-amylase (EC 3.2.1.1), rat intestinal α-
glucosidase (EC 3.2.1.20), hippuric acid, 2,2-diphenyl-1-picrylhydrazyl (DPPH), rabbit 
lung ACE (EC 3.4.15.1), cinnamic acid, rosmarinic acid, protocatechuic acid, p-coumaric 
acid, chlorogenic acid, caffeic acid, ferulic acid, and quercetin were purchased from 
Sigma Chemical Co. (St. Louis, MO). 
 
4.3.3.2 Sample Preparation 
 
Water Extracts:  
 The samples (2.5 g) were extracted in 100 mL of distilled water under reflux at 
95°C for 30 minutes. The samples were centrifuged for 10 minutes and stored in a 
refrigerator at -20°C until analysis, for no more than 1 week.  
 
Ethanol extracts:  
 The samples (2.5 g) were extracted in 100 mL of 12% ethanol in a shaker at a 
speed of 150 RPM overnight at 20°C. The samples were filtered and stored in a 
refrigerator at –20°C until analysis, for no more than 1 week. 
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 4.3.3.3 Total Phenolic Assay 
 
The total phenolics in all samples were determined by using a method modified 
by Shetty et al. (1995). In brief, 0.5 mL of sample extract was added to a test tube and 
mixed with 0.5 mL of 95% ethanol and 5 mL of distilled water. To each sample, 0.5 mL 
of 50% (vol/vol) Folin-Ciocalteu reagent was added and mixed. The absorbance was read 
at 725 nm using a spectrophotometer (Genesys UV/Visible, Milton Roy, Inc., Rochester, 
NY). Different concentrations of gallic acid were used to develop a standard curve. 
Results were expressed as mg of gallic acid/g of sample dry weight (DW). 
 
4.3.3.4 Antioxidant Activity by DPPH Radical Inhibition Assay 
 
The antioxidant activity was determined by the DPPH radical scavenging method 
modified from Kwon et al. (2006). A 250-μL aliquot of the sample extract was mixed 
with 1,250 μL of DPPH (60 μM in ethanol). The mixture was centrifuged at 13,000 g for 
1 minute, and after this the absorbance was measured at 517 nm using the Genesys 
UV/Visible spectrophotometer. The readings were compared with the controls, 
containing 95% ethanol instead of sample extract. The percentage inhibition was 
calculated by: 
 
% inhibition =  (Absorbancecontrol − Absorbanceextract )
Absorbancecontrol
×100 
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 4.3.3.5 α-Amylase Inhibition Assay 
 
 The α-amylase inhibitory activity was determined by an assay modified from the 
Worthington Enzyme Manual (Worthington, 1993). A total of 500 µL of sample extract 
and 500 µL of 0.02 M sodium phosphate buffer (pH 6.9 with 0.006 M NaCl) containing 
α-amylase solution (0.5 mg/mL) were incubated at 25°C for 10 minutes. After 
preincubation, 500 µL of a 1% starch solution in 0.02 M sodium phosphate buffer (pH 
6.9 with 0.006 M NaCl) was added to each tube at timed intervals. The reaction was 
stopped with 1.0 mL of dinitrosalicylic acid color reagent. The test tubes were incubated 
in a boiling water bath for 5 minutes and cooled to room temperature. The reaction 
mixture was then diluted after adding 5-15 mL of distilled water, and the absorbance was 
measured at 540 nm using the Genesys UV/Visible spectrophotometer. The readings 
were compared with the controls, containing buffer instead of sample extract. The 
percentage α-amylase inhibitory activity was calculated with the same equation as for 
percentage inhibition in the DPPH radical inhibition assay. 
 
4.3.3.6 α-Glucosidase Inhibition Assay 
 
The α-glucosidase inhibitory activity was determined by an assay modified from 
McCue et al. (2005). α-Glucosidase was assayed by using 50 μL of sample extracts and 
100 μL of 0.1 M phosphate buffer (pH 6.9) containing α-glucosidase solution (1 U/mL) 
and was incubated in 96-well plates at 25°C for 10 min. After preincubation, 50 μL of 5 
mM p-nitrophenyl-α-d-glucopyranoside solution in 0.1 M phosphate buffer (pH 6.9) was 
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 added to each well at timed intervals. The reaction mixtures were incubated at 25°C for 5 
min. Before and after incubation, absorbance readings were recorded at 405 nm by a 
microplate reader (Thermomax, Molecular Devices Co., Sunnyvale, CA) and compared 
to a control that had 50 μL of buffer solution in place of the extract. The α-glucosidase 
inhibitory activity was expressed as percentage inhibition and was calculated with the 
same equation as for percentage inhibition in the DPPH radical inhibition assay. Dose 
dependency was tested using 10 µL and 25 µL of the sample, the volume made up to 50 
µL using 0.1 M phosphate buffer (pH 6.9) and same protocol was followed. 
 
4.3.3.7 ACE Inhibition Assay 
 
ACE inhibition was assayed by a method modified by Kwon et al. (2006). The 
substrate hippuryl-histidyl-leucine (HHL) and the enzyme ACE-I from rabbit lung (EC 
3.4.15.1) were used. Fifty μL of sample extracts were incubated with 100 μL of 1 M 
NaCl-borate buffer (pH 8.3) containing 2 mU of ACE-I solution at 37°C for 10 min. 
After preincubation, 100 μL of a 5 mU substrate (HHL) solution was added to the 
reaction mixture. Test solutions were incubated at 37°C for 1 hour. The reaction was 
stopped with 150 μL of 0.5 N HCl. Five μl of the sample was injected in a high-
performance liquid chromatography (HPLC) apparatus (Agilent 1100 series equipped 
with autosampler and DAD 1100 diode array detector, Agilent Technologies, Palo Alto, 
CA). The solvents used for gradient were (1) 10 mM phosphoric acid (pH 2.5) and (2) 
100% methanol. The methanol concentration was increased to 60% for the first 8 min and 
to 100% for 5 min and then was decreased to 0% for the next 5 min (total run time, 18 
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 min). The analytical column used was an Agilent Nucleosil 100-5C18, 250 mm × 4.6 mm 
inside diameter, with packing material of 5 μm particle size at a flow rate of 1 ml/min at 
ambient temperature. During each run, the absorbance was recorded at 228 nm, and the 
chromatogram was integrated using the Agilent Chemstation (Agilent Technologies) 
enhanced integrator for detection of liberated hippuric acid (A). Hippuric acid standard 
was used to calibrate the standard curve and retention time. The percentage inhibition 
was calculated by: 
% inhibition =  (Acontrol − Aextract )
(Acontrol − Ablank )
×100
 
 
4.3.3.8 HPLC Analysis of Phenolic Phytochemicals 
 
Two milliliters of the extracts was filtered (pore size, 0.2 μm), and 5 μL was 
injected in the HPLC apparatus (Agilent 1100 series equipped with autosampler and 
DAD 1100 diode array detector). The solvents used for gradient elution were (A) 10 mM 
phosphoric acid (pH 2.5) and (B) 100% methanol. The methanol concentration was 
increased to 60% for the first 8 minutes and to 100% over the next 7 minutes, then 
decreased to 0% for the next 3 minutes, and maintained for the next 7 minutes (total run 
time, 25 minutes). The analytical column used was an Agilent Zorbax SB-C18, 250 mm 
× 4.6 mm i.d., with packing material of 5 μm particle size at a flow rate of 1 mL/minute 
at ambient temperature. During each run the absorbance was recorded at 306 nm and 333 
nm, and the chromatogram was integrated using the Agilent Chemstation enhanced 
integrator. Calibration was performed by injecting the standards of cinnamic acid, 
rosmarinic acid, protocatechuic acid, p-coumaric acid, chlorogenic acid, caffeic acid, 
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 ferulic acid, and quercetin. Peak identification was performed by comparison of retention 
times and diode array spectral characteristics with the standards. The results were 
expressed as μg/g of sample DW. 
 
4.3.3.9 Statistical Analysis 
 
All experiments were performed in either duplicates or triplicates. Analysis at 
every time point from each experiment was carried out in duplicate or triplicate. Means, 
standard errors and standard deviations were calculated from replicates within the 
experiments and analyzed using Microsoft Excel XP. 
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 4.3.4 Results and Discussion 
 
4.3.4.1 Total Phenolics and Antioxidant Activity by DPPH Inhibition 
 
 In this study, we focused on aqueous and ethanolic extracts of two species 
common to Near East regions of Asia belonging to Lamiaceae family. Samples were 
screened for their anti-hyperglycemia and anti-hypertension potential based on in vitro 
assays relevant to development of biochemical rationale for management of type II 
diabetes in the early stages. Figure 16 shows the total phenolic content of aqueous 
extracts for Origanum majorana (Marjoram) and Salvia libanotica (Sage). Total phenolic 
content for aqueous extract of marjoram was observed to be 41.15 mg/g of sample dry 
weight (DW), and sage was 38.4 mg/g of sample DW. Total phenolic content observed 
for ethanolic extracts of sage and marjoram was lower than that observed for aqueous 
extracts. High concentration of phenolic phytochemicals observed in oregano previously 
suggests that it has high antioxidant and antimicrobial activity (Chun et al., 2005). Figure 
17 shows phenolic content for ethanolic extracts of marjoram (22.15 mg/g of sample 
DW) and sage (16.7 mg/g of sample DW). Extraction process for aqueous extracts was 
carried out under higher temperatures than ethanolic extracts, and therefore resulted in 
higher extractable phenolic content for marjoram and sage (Seaberg et al., 2003; Chun et 
al., 2005). The high phenolic content indicates the relevance for hyperglycemia linked to 
type II diabetes (Kwon et al., 2006). High phenolic content indicates the potential of 
ingestion of sage and marjoram in various food designs and combinations to slow down 
and delay in development of type II diabetes. 
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  Total antioxidant activity measured by DPPH inhibition assay indicated similar 
results for aqueous and ethanolic samples of sage and marjoram, although the phenolic 
content showed a difference (Figure 16 & 17). The % inhibition of DPPH ranged from 
76.6% to 79.6% for aqueous and ethanolic extracts of the samples. This suggests that 
total phenolic content may not be totally important in determining antioxidant activity of 
the extracts, but the physico-chemical nature of individual phenolics may play a part 
(Chun et al., 2005). Figure 16 shows the results obtained for total antioxidant activity by 
DPPH assay for aqueous extracts of Origanum majorana (Marjoram) and Salvia 
libanotica (Sage), with a correlation of total phenolic content. Total antioxidant activity 
measured for aqueous extracts of marjoram was observed to be 77.5% DPPH inhibition, 
which was lower than that observed for sage (79%). There was no significant difference 
seen between the two Lamiaceae samples because of their similar phytochemical 
compositions, but the polyphenol content was higher in aqueous extracts of sage. Figure 
17 shows the total antioxidant activity observed for ethanolic extracts of Origanum 
majorana (Marjoram) and Salvia libanotica (Sage). The % DPPH inhibition measured for 
ethanolic extracts of marjoram (79.6%) was higher compared to aqueous extracts. Total 
antioxidant activity observed for sage (76.6%) was lower than the value observed for 
aqueous extracts. High % DPPH inhibition of sage and marjoram indicates that, total 
phenolic content in this case cannot be the basis of prediction for total antioxidant activity 
(Kahkonen et al., 1999; Parejo et al., 2002). Total phenolic content for aqueous extracts 
indicated an inverse (r = -1) correlation with % DPPH inhibition. But, a high correlation 
(r = 1) was observed between total phenolic content and % DPPH inhibition for ethanolic 
extracts. High antioxidant activity of sage and marjoram suggests that, plant derived 
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 additives from herbs and spices could prove to be beneficial towards prevention of 
oxidative stress, and could be potentially beneficial in managing the micro vascular 
complications of type II diabetes (Kwon et al., 2006). Such findings could prove that, 
substitution of plant extracts for synthetic food antioxidants has potential to influence 
human health (Martinez-Tome et al., 2001; Hinneburg et al., 2006). Total phenolic 
content and total antioxidant activity by DPPH assay indicates that these plants, which 
are commonly consumed in Mediterranean diet (Parejo et al., 2002), can prove to be 
protective against oxidative stress with cross-over beneficial affects on human health. 
These herbs could prove to have potential to be industrially efficient due to their high 
phenolic antioxidant activity, which helps in slowing down oxidative degradation of 
lipids (Wojdylo et al., 2007), and improving the quality and nutritional value of food. 
High total antioxidant activity measured via DPPH assay also indicates the potential that 
these antioxidants might play an important part in suppressing oxidative stress caused to 
pancreatic beta cell function, which may reduce the incidence of type II diabetes (Song et 
al., 2005; Bhandari et al., 2008). Therefore, it can be concluded that, specific phenolic 
compounds responsible for high antioxidant activity may serve as a preventive measure 
against the development of type II diabetes, if applied through better food designs and 
combinations for dietary management in early stages. 
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Figure 16 Total Soluble Phenolics (mg GAE/ g DW ± Standard Error) and Total 
Antioxidant Activity (% DPPH Inhibition ± Standard Error) correlation of aqueous 
extracts of Origanum majorana (Marjoram) and Salvia libanotica (Sage). 
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Figure 17 Total Soluble Phenolics (mg GAE/ g DW ± Standard Error) and Total 
Antioxidant Activity (% DPPH Inhibition ± Standard Error) correlation of ethanolic 
extracts of Origanum majorana (Marjoram) and Salvia libanotica (Sage). 
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  4.3.4.2 α–Glucosidase Inhibition 
 
 Type II diabetes is growing rapidly globally mainly due to the diet and lifestyle 
changes leading to obesity in general population. A therapeutic approach to decrease 
postprandial hyperglycemia is by slowing the absorption of glucose, by inhibition of 
α-glucosidase enzyme in digestive system (Bhandari et al., 2008). Therefore, we 
investigated inhibitory activity of α-glucosidase inhibitors in aqueous and ethanolic 
extracts of sage and marjoram. 
 Dose dependency studies (10µl, 25µl, 50µl) indicated dose dependent responses, 
where the highest inhibition was observed for samples with no dilution and the lowest 
inhibition was seen for 1/5 diluted samples. Therefore as the sample dilution 
increased, % inhibition was seen to decrease. Figure 18 indicates results for dose 
dependent studies using extracts of sage and marjoram, which ranged from 55% 
(Sage, 1/5 dilution sample) to 85.6% (Marjoram, no dilution sample). Aqueous 
extracts of marjoram indicated higher α-glucosidase inhibitory activity than sage in 
all dose dependent studies of sample extracts. Aqueous extracts of sage and marjoram 
had a high α-glucosidase inhibitory activity, which also had a high content of 
rosmarinic acid (Table 6). Total phenolic content for aqueous extracts showed a high 
correlation (r = 1) with α-glucosidase inhibition. This suggests that there may be 
some specific phenolic compounds which could be responsible for high α-
glucosidase inhibitory activity of the sample extracts. Total phenolic content for 
ethanolic extracts showed an inverse correlation (r = -1) with α-glucosidase inhibitory 
activity. Unlike aqueous extracts of the samples, where a high correlation was seen 
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 for total phenolic content and α-glucosidase inhibition, ethanolic extracts showed 
opposite results with no correlation. The phenolic profile of ethanolic extracts (Table 
1), low content of rosmarinic acid was observed, but the content of rutin was 
observed to be higher for sage compared to aqueous extracts, where no rutin content 
was found. Therefore, based on the results we can suggest that, Lamiaceae samples 
with phenolic compound such as rosmarinic acid, caffeic acid and rutin could 
potentially contain hypoglycemic affects due to their high α-glucosidase inhibitory 
activities. 
 Figure 19 shows the results for α-glucosidase inhibition for ethanolic extracts of 
sage and marjoram. Compared to aqueous extracts of the samples, ethanolic extracts 
showed higher α-glucosidase inhibitory activity for sage, which ranged from 69% 
(1/5 sample dilution) to 79% (no sample dilution). These results suggest that, 
inhibitory activity for sage could potentially be higher in ethanolic extracts due to a 
certain phenolic compounds being efficiently extracted that are not present in aqueous 
extracts, such as rutin (Table 6). Inhibitory activity for marjoram was observed to be 
lower than aqueous extracts, which ranged from 62.6% (1/5 sample dilution) to 70%. 
Correlations between DPPH assay and α-glucosidase inhibition illustrates an inverse 
activity (r = -1) for both aqueous and ethanolic extracts. This suggests that, 
antioxidant activity may not totally affect the α-glucosidase inhibitory activity of 
these Lamiaceae samples, even though the percent inhibitory activities were seen to 
be higher for both assays. High α-glucosidase inhibitory activity suggests that, sage 
and marjoram have anti-diabetic potentials observed in both aqueous and ethanolic 
extracts. Results for sage and marjoram varied for ethanolic and aqueous extracts, 
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 with higher inhibition for marjoram in aqueous extracts and being high for sage in 
ethanolic extracts. Therefore, we can assume that, enrichment of Lamiaceae herbs in 
our diet through condiments or other ways could result in enhancement of our health 
through functional bioactive enrichment of foods. This could be seen in terms of α-
glucosidase inhibition relevant to hyperglycemia which is linked to type II diabetes 
management. Lamiaceae species such as sage and marjoram have high α-glucosidase 
inhibitory activities for both ethanolic and aqueous extracts, suggesting that the 
inclusion of these high phenolic herbs in our diet could help reduce blood glucose 
levels and lengthen the duration of carbohydrate absorption (Ye et al., 2002; Kwon et 
al., 2006). Lowering of blood glucose level to normal is the most important part of 
treating persistent hyperglycemia, which is the characteristic of type II diabetes (Ye et 
al., 2002). Synthetic forms of α-glucosidase inhibitors are known to come with 
various side effects, and toxicity being one of them, is allowing people to explore 
alternative strategies, such as developing natural plant food-based strategies through 
effective dietary management. Therefore, natural forms of α-glucosidase inhibitors 
present in sage and marjoram could serve potentially to be an important way to 
suppress elevated blood glucose levels, due to hyperglycemia linked to the incidence 
of type II diabetes. 
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Figure 18 Changes observed in dose dependent (10 µL, 25 µL, 50 µL) % α-glucosidase 
inhibitory activities for aqueous extracts of Origanum majorana (Marjoram) and Salvia 
libanotica (Sage). 
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Figure 19 Changes observed in dose dependent (10 µL, 25 µL, 50 µL) % α-glucosidase 
inhibitory activities for ethanolic extracts of Origanum majorana (Marjoram) and Salvia 
libanotica (Sage). 
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 Table 6 Phenolic Profile (mg/g of sample DW ± Standard Error) Analysis of Lamiaceae 
Family for Aqueous and Ethanolic Extracts. Analysis of Phenolic Compounds: 
Rosmarinic Acid, Caffeic Acid and Rutin. 
 
Sample 
Rosmarinic 
Acid 
Caffeic 
Acid Rutin 
 mg/g DW mg/g DW mg/g DW 
H2O    
Origanum 
majorana 27.4 ± 0.72 
  
Salvia libanotica 39.7 ± 0.53 2.73 ± 0.14  
    
ETHANOL    
Origanum 
majorana 5.13 ± 3.32 8.00 ± 1.15 
 
Salvia libanotica 2.60 ± 0.12  15.0 ± 0.40 
 
 
4.3.4.3 α-Amylase Inhibition 
 
 α-Amylase serves a role similar to α-glucosidase, by managing hyperglycemia 
linked to type II diabetes (Pinto et al., 2009). In vitro α-amylase inhibition was 
evaluated for ethanolic and aqueous extracts of Origanum majorana (Marjoram) and 
Salvia libanotica (Sage). No α-amylase inhibition was observed for either extracts of 
both samples. Sage and marjoram may not have some specific compounds present, 
which could cause it modulate α-amylase inhibition (Kwon et al., 2006). Though the 
samples did not indicate any α-amylase inhibition, but high α-glucosidase inhibition 
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 suggests that it could still serve as a food ingredient and condiment that can be used 
to help manage hyperglycemia linked to type II diabetes. 
 
4.3.4.4 ACE Inhibition 
 
 Hypertension is a risk factor for the advancement of cardiovascular diseases, 
which is a long term macro vascular complication of type II diabetes (Kwon et al., 2006). 
Development of natural food sources to help manage hypertension is of interest and a 
lower cost option. There was no ACE inhibition observed for the select species of family 
Lamiaceae in this study. We suspect that the reason behind not observing ACE inhibition 
for Lamiaceae samples could be due to the amount of sample (2.5g), which was used to 
prepare sample extracts. We can assume that, total phenolic content and total antioxidant 
activity did not influence the results obtained for ACE inhibition. This suggests that there 
may be other phenolic compounds or peptides not enriched in these extracts linked to 
ACE inhibition of sage and marjoram. (Kwon et al., 2006) 
 
4.3.4.5 HPLC Analysis of Phenolic Phytochemicals 
 
 Three different major phenolic compounds were observed in ethanolic and 
aqueous extracts of Origanum majorana (Marjoram) and Salvia libanotica (Sage). These 
compounds include rosmarinic acid, caffeic acid and rutin, and amounts (mg/g DW) and 
their standard errors are indicated in Table 7, for both aqueous and ethanolic extracts. 
Rosmarinic acid observed for aqueous extracts of sage and marjoram showed a higher 
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 content than ethanolic extracts. Rosmarinic acid content for aqueous extracts ranged from 
27.4 mg/g (Marjoram) to 39.7 mg/g (Sage) of sample DW, where it ranged from 2.6 mg/g 
(Sage) to 5.1 mg/g (Marjoram) for ethanolic extracts. Rosmarinic acid is abundantly 
found in plants belonging to Lamiaceae family (Shetty, 1997; Peterson and Simmonds, 
2003). Rosmarinic acid is known to provide protection against cancer and contains high 
antioxidant activity (Peteron and Simmonds, 2003), which may be the reason a high total 
antioxidant activity was observed for sage and marjoram. Presence of this particular 
phenolic compound in our diet as a natural food source would have the potential to 
manage hyperglycemia and associated obesity, preventing the incidence of type II 
diabetes. Additional in vivo studies are needed to understand the antioxidant, anti-
inflammatory and anti-diabetic chemopreventive affects of rosmarinic acid from 
Lamiaceae plants on human health using optimized whole food extracts. 
 The content of phenolic compound, caffeic acid was observed in both aqueous 
and ethanolic extracts of the samples. The content in sage was 2.7 mg/g DW in the 
aqueous extracts, and marjoram 8 mg/g DW in ethanolic extracts. Caffeic acid is known 
to play an important part in fruits and vegetables as an antioxidant, due to which we 
relate its actions for potential prevention of chronic illnesses such as cardiovascular 
diseases and cancer. Another phenolic compound that we observed in ethanolic extracts 
of marjoram was rutin. Rutin content was 15 mg/g of sample DW. Phenolic flavonoids 
such as rutin, are commonly found in many fruits and vegetables, and are used to provide 
protection against development of vascular diseases (Schramm and German, 1998). This 
gives us some evidence on how the presence of rutin in ethanolic extract of sage could 
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 prove to be potentially beneficial towards managing hypertension linked to type II 
diabetes though in vitro studies did not indicate such activity in this investigation. 
 
Table 7 Phenolic Profile (mg/g of sample DW ± Standard Error) Analysis of Lamiaceae 
Family for Aqueous and Ethanolic Extracts. Analysis of Phenolic Compounds: 
Rosmarinic Acid, Caffeic Acid and Rutin. 
 
Sample 
Rosmarinic 
Acid 
Caffeic 
Acid Rutin 
 mg/g DW mg/g DW mg/g DW 
H2O    
Origanum 
majorana 27.4 ± 0.72 
  
Salvia libanotica 39.7 ± 0.53 2.73 ± 0.14  
    
ETHANOL    
Origanum 
majorana 5.13 ± 3.32 8.00 ± 1.15 
 
Salvia libanotica 2.60 ± 0.12  15.0 ± 0.40 
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 4.3.5 Conclusions 
 
 Main focus of this research study was to evaluate anti-hyperglycemia and 
antihypertensive potential of 2 select species (Origanum majorana and Salvia 
libanotica), of Lamiaceae family common in Near East of Asia. Samples were prepared 
through hot water and 12% ethanol extractions. In vitro functionality assays such as total 
soluble phenolics and inhibition assays like DPPH, α-glucosidase, α-amylase and ACE 
were evaluated for these select herbs to explore potential for hyperglycemic and 
hypertensive management. No ACE and α-amylase inhibition was observed for sage and 
marjoram, which could be due to absence of certain phenolic compounds in evaluated 
samples. α-Glucosidase inhibition for ethanolic and aqueous extracts of select samples 
ranged from 55% (Sage, 1/5 dilution sample) to 85.6% (Marjoram, no dilution sample). 
High α-glucosidase inhibition activity indicates that inclusion of herbs from Lamiaceae 
family could potentially help manage hyperglycemia linked to type II diabetes. Total 
phenolic content ranged upto 41.1 mg/g of sample DW, along with high DPPH inhibition 
which ranged upto almost 80%. High phenolic antioxidant activity suggests that certain 
phenolic compounds are present in select species, which could prove to be beneficial 
towards human health if included as part of food designs for a healthy diet. This research 
provides biochemical rationale for clinical studies on functional benefits of sage and 
marjoram from Lamiaceae family, which could further be applied in in vivo studies for 
development and innovation of therapeutic strategies, to prevent and manage type II 
diabetes. 
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